Document:

Exhibit 10.5

 

 

 

 

 

 

 

 

 

 

 

WARRANT

 

to Purchase Common Stock of

 

Cadiz Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrant No. W-2

Original Issue Date: July 2, 2021

 

     

    

    

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
MAY NOT BE SOLD OR TRANSFERRED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE SECURITIES ACT OR (II)
THE TRANSACTION IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.

 

	Original Issue Date: July 2, 2021	Warrant No. W-2

 

Warrant

 

to Purchase 500,000 Shares (Subject to Adjustment)
of Common Stock of

 

Cadiz Inc.

 

THIS IS TO CERTIFY THAT B. Riley Principal Investments, LLC (“Investor”),
or its registered assigns, is entitled, at any time during the Exercise Period (subject to Section 2.1(a)) to purchase from Cadiz Inc.,
a Delaware corporation (the “Company”), 500,000 shares (subject to adjustment
as provided herein) of the common stock, par value $0.01 per share, of the Company at a purchase price per share equal to $21.72 (the
initial “Exercise Price,” subject to adjustment as provided herein).

 

This Warrant was issued in
connection with that certain Credit Agreement (the “Credit Agreement”), dated as of July 2, 2021 (the “Effective
Date”), by and among the Company, as a borrower, Cadiz Real Estate LLC, as a borrower, B. Riley Commercial Capital, LLC, as
a lender, the other lenders party thereto, and B. Riley Securities, Inc., as agent (the “Agent”), and is subject to
the terms thereof.

 

		1.	DEFINITIONS

 

As used in this Warrant, the
following terms have the respective meanings set forth below, and to the extent such terms have the respective meaning set forth in the
Credit Agreement, such terms shall have such meaning as set forth in the Credit Agreement, provided, however, that if such
Credit Agreement is expired, terminated or otherwise discharged, such terms shall have the meaning set forth in the Credit Agreement immediately
prior to such expiration, termination or discharge:

 

“10-Day
VWAP” for any date of determination means the per share volume-weighted average price of Common Stock, as displayed under
the heading “Bloomberg VWAP” on Bloomberg page CDZI <equity> VWAP (or its equivalent successor if such page is not available),
from the scheduled open of trading until the scheduled close of trading of the primary trading session of the NASDAQ Global Market on
each trading day during the 10 consecutive trading day period preceding (but not including) such date of determination (or if such volume-weighted
average price is unavailable, the market value of one share of Common Stock during such period determined, using a volume-weighted average
method, by a nationally recognized independent investment banking firm retained for this purpose by the Company). The VWAP will be determined
without regard to after-hours trading or any other trading outside of the regular trading session trading hours.

 

     

     

    

 

“Affiliate”
of, or a Person “Affiliated” with, a specified Person means any other Person
directly or indirectly controlling, controlled by, or under common control with, that Person. For the purposes of this definition, “control”
(including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control
with”), as applied to any Person, means the possession, directly or indirectly, of the power (i) to vote 20% or more of the securities
having ordinary voting power for the election of directors (or persons performing similar functions) of such Person, or (ii) to direct
or cause the direction of the management and policies of that Person, whether by contract or otherwise.

 

“Agent”
shall have the meaning set forth in the preamble to this Warrant.

 

“Aggregation Date”
shall have the meaning set forth in Section 5.2 hereof.

 

“Applicable
Rate” shall have the meaning ascribed to such term in the Credit Agreement.

 

“Appraisal
Procedure” means the following procedure to determine the fair market value, as to any security, for purposes of the
definition of “Fair Market Value“ or the fair market value, as to any other
property (in either case, the “Valuation Amount“). The Valuation Amount shall
be determined in good faith jointly by the Company and the Required Holders; provided, however, that if such parties are
not able to agree on the Valuation Amount within a reasonable period of time (not to exceed 20 Business Days), the Valuation Amount shall
be determined by the mutual agreement of two independent appraisers, one appointed by the Company and one appointed by the Required Holders,
with each appointed within 10 days of the Appraisal Procedure having been first invoked by the Required Holders. The Company and the Required
Holders shall submit their respective valuations and other relevant data to the appraisers, and the appraisers shall, within 20 days of
the later of the two appraisers’ appointment dates, mutually agree to a determination of the Valuation Amount. If such appraisers
cannot mutually agree on the Valuation Amount by such date, a third independent appraiser shall be chosen within 10 days of such date
by the mutual consent of the first two appraisers. Such third appraiser shall make a determination of the Valuation Amount within 20 days
of its appointment. If three appraisers shall have been appointed and made determinations of the Valuation Amount, then the average of
the three Valuation Amounts shall be final and binding on the Company and the Required Holders as the final Valuation Amount, provided,
however, that if the determination of one appraiser differs by an amount equal to more than twice that of the middle of the three
appraisers’ Valuation Amounts (the “Outlier Appraiser”), then the determination of the Outlier Appraiser shall
be excluded from determining the final Valuation Amount and the remaining two appraisers’ determinations of the Valuation Amount
shall be averaged and such average shall be final and binding upon the Company and the Required Holders as the final Valuation Amount.
The Company shall pay all of the fees and expenses incurred in conducting the Appraisal Procedure.

 

“beneficial owner”
and “beneficially own” shall have the meaning set forth under Section 13(d) of the Exchange Act.

 

“Beneficial Ownership
Limitation” has the meaning set forth in Section 5.1 hereof.

 

“Business
Day” shall have the meaning ascribed to such term in the Credit Agreement.

 

    2

     

    

 

“Commission”
means the Securities and Exchange Commission or any other federal agency then administering the Securities Act and other federal securities
laws.

 

“Common
Stock” means the common stock, par value $0.01 per share, of the Company as constituted on the Original Issue Date, and
any capital stock into which such Common Stock may thereafter be changed, and shall also include (i) capital stock of the Company of any
other class (regardless of how denominated) issued to the holders of shares of any Common Stock upon any reclassification thereof which
is also not preferred as to dividends or liquidation over any other class of stock of the Company and which is not subject to redemption
and (ii) shares of common stock of any successor or acquiring corporation received by or distributed to the holders of Common Stock of
the Company in the circumstances contemplated by Section 4.6 hereof.

 

“Company”
shall have the meaning set forth in the preamble to this Warrant.

 

“Credit
Agreement” shall have the meaning set forth in the preamble to this Warrant.

 

“Delivery
Notice” shall have the meaning set forth in Section 5.1(c) hereof.

 

“Designated
Office” shall have the meaning set forth in Section 9 hereof.

 

“DOJ” shall
have the meaning set forth in Section 6.4 hereof.

 

“DTC” shall
have the meaning set forth in Section 2.1(b) hereof.

 

“DWAC”
shall have the meaning set forth in Section 2.1(b) hereof.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated
thereunder, all as the same shall be in effect at the time.

 

“Exercise
Date” shall have the meaning set forth in Section 2.1(a) hereof.

 

“Exercise
Notice” shall have the meaning set forth in Section 2.1(a) hereof.

 

“Exercise
Period” means the period commencing one hundred eighty (180) days after the Original Issue Date, and before 4:00 P.M.,
Eastern Standard Time, on the Expiration Date.

 

“Exercise
Price” means, in respect of a share of Warrant Stock at any date herein specified, the initial Exercise Price set forth
in the preamble of this Warrant, as adjusted from time to time pursuant to Article 4 hereof.

 

“Expiration
Date” means the third anniversary of the Original Issue Date, to be extended to allow for delayed exercise and delivery
of any Warrant Stock in accordance with Section 5.1(c) hereof.

 

“Expiration Warrant
Stock” shall have the meaning set forth in Section 5.1(c) hereof.

 

    3

     

    

 

“Fair
Market Value” means (i) as to any Common Stock listed or quoted on a Trading Market, the 10-Day VWAP determined in respect
of such primary Trading Market and (ii) as to any Common Stock not listed or quoted on a Trading Market or any other security, (A) the
Ten Day Average of the average closing prices of such security’s sales on all domestic securities exchanges on which such security
may at the time be listed, or (B) if there have been no sales on any such exchange such that the foregoing Ten Day Average cannot be calculated,
the average of the highest bid and lowest asked prices on all such exchanges at the end of the Business Day immediately prior to the date
that Fair Market Value is determined as of, or (C) if on any day such security is not listed any domestic securities exchange such that
neither the foregoing Ten Day Average nor the foregoing bid-and-asked price average can be calculated, the average of the highest bid
and lowest asked prices at the end of the Business Day immediately prior to the date that Fair Market Value is determined in the domestic
over-the-counter market as reported by the National Association of Securities Dealers Automated Quotation System or similar organization
(and in each such case excluding any trades that are not bona fide, arm’s length transactions). If neither the foregoing clause
(i) nor clause (ii) is applicable, then (i) the “Fair Market Value” of such security as of an applicable determination date
shall be as determined in accordance with the Appraisal Procedure.

 

“FTC” shall
have the meaning set forth in Section 6.4 hereof.

 

“Governmental
Authority” shall have the meaning set forth in the Credit Agreement.

 

“Holder“”
means with respect to any Warrant or share of Warrant Stock, the Person in whose name the Warrant or Warrant Stock is registered on the
books of the Company maintained for such purpose.

 

“Holder Group”
shall have the meaning set forth in Section 5.1(d) hereof.

 

“HSR Act”
shall have the meaning set forth in Section 6.4 hereof.

 

“Investor”
shall have the meaning set forth in the preamble to this Warrant.

 

“Lien”
means (i) any lien, mortgage, pledge, assignment, security interest, charge or encumbrance of any kind (including any agreement to give
any of the foregoing, any conditional sale or other title retention agreement, and any lease in the nature thereof) and any option, trust
or other preferential arrangement having the practical effect of any of the foregoing, and (ii) in the case of securities, any purchase
option, call or similar right of a third party with respect to such securities.

 

“Maximum Percentage”
shall have the meaning set forth in Section 5.1 hereof.

 

“Original
Issue Date” means July 2, 2021, the date on which this Warrant was issued by the Company pursuant to the Credit Agreement.

 

“Outlier Appraiser”
shall have the meaning set forth in Article 1 hereof.

 

“Outstanding”
means, subject to Section 5.1(d) hereof, when used with reference to Common Stock, at any date as of which the number of shares thereof
is to be determined, all issued and actually outstanding shares of Common Stock, except shares then owned or held by or for the account
of the Company or any Subsidiary, and shall include all shares issuable in respect of outstanding scrip or any certificates representing
fractional interests in shares of Common Stock.

 

    4

     

    

 

“Person”
means and includes natural persons, corporations, limited partnerships, general partnerships, limited liability companies, limited liability
partnerships, joint stock companies, joint ventures, associations, companies, trusts, banks, trust companies, land trusts, business trusts
or other organizations, whether or not legal entities, and Governmental Authority.

 

“Reference Price”
shall have the meaning set forth in Section 4.1 hereof.

 

“Related Issuances”
shall have the meaning set forth in Section 5.2 hereof.

 

“Required Holders”
means holders of outstanding Warrants representing more than 50% of the Warrant Stock issuable upon exercise of such outstanding Warrants.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder,
all as the same shall be in effect at the time.

 

“Stockholder Approval”
means the approval by the stockholders of the Company for purposes of terminating the issuance cap in respect of shares of Common Stock
set forth in Section 5.2 hereof.

 

“Subsidiary”
means any corporation, association, trust, limited liability company, partnership, joint venture or other business association or entity
(i) at least 50% of the Outstanding voting securities of which are at the time owned or controlled, directly or indirectly, by the Company;
or (ii) with respect to which the Company possesses, directly or indirectly, the power to direct or cause the direction of the affairs
or management of such Person.

 

“Ten
Day Average” means, with respect to any prices and in connection with the calculation of Fair Market Value, the average
of such prices over the ten consecutive Business Days ending on the Business Day immediately prior to the day as of which “Fair
Market Value” is being determined.

 

“Trading Day”
means any day that the primary Trading Market on which the Common Stock is listed or quoted is open for trading.

 

“Trading Market”
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or
OTCQX (or any successors to any of the foregoing).

 

“Transfer Agent”
shall have the meaning set forth in Section 2.1(b) hereof.

 

“Valuation Amount”
shall have the meaning set forth in Article 1 hereof.

 

“Warrant
Price” means an amount equal to (i) the number of shares of Warrant Stock being purchased upon exercise of this Warrant
pursuant to Section 2.1 hereof, multiplied by (ii) the Exercise Price.

 

    5

     

    

 

“Warrant”
means this Warrant and all warrants issued upon transfer, division or combination of, or in substitution for, this Warrant, or any other
like warrant subsequently issued to the Holder. All such foregoing warrants shall at all times be identical as to terms and conditions,
except as to the number of shares of Warrant Stock for which they may be exercised and their date of issuance.

 

“Warrants”
means this Warrant and all other warrants to purchase Common Stock, in the same form as this Warrant, issued to the lenders party to the
Credit Agreement.

 

“Warrant
Stock” means the shares of Common Stock issued, issuable or both (as the context may require) upon the exercise of this
Warrant.

 

		2.	EXERCISE OF WARRANT

 

2.1 Manner
of Exercise.

 

(a) At
any time during the Exercise Period, the Holder of this Warrant may from time to time exercise this Warrant, on any Business Day, for
all or any part of the number of shares of Warrant Stock (subject to adjustment as provided herein) purchasable hereunder; provided,
in the event all amounts due under the Loan Documents (as defined in the Credit Agreement), including but not limited to, all outstanding
principal amount and unpaid interests, are paid in full within one hundred eighty (180) days after the Original Issue Date, this Warrant
shall not become exercisable and shall instead terminate upon such payment in full. In order to exercise this Warrant, in whole or in
part, the Holder shall (i) deliver to the Company at its Designated Office a written notice of the Holder’s election to exercise
this Warrant (an “Exercise Notice“) substantially in the form attached to
this Warrant as Annex A, which Exercise Notice shall be irrevocable and specify the number of shares of Warrant Stock to be purchased,
together with this Warrant and (ii) pay to the Company the Warrant Price (in accordance with one of the methods specified in Section 2.1(c)
hereof). The date on which such delivery and payment shall have taken place being hereinafter referred to as the “Exercise
Date.” Except as otherwise provided in this Section 2.1(a), any payment after the Original Issue Date of all remaining
principal and interest outstanding under the Credit Agreement shall not affect the ability of the Holder to exercise this Warrant.

 

(b) Subject
to Article 5 hereof, upon receipt by the Company of such Exercise Notice, surrender of this Warrant and payment of the Warrant Price (in
accordance with Section 2.1(c) hereof), the Company shall cause its Transfer Agent to deliver the applicable shares of Warrant Stock,
and the Company shall deliver or cause to be delivered cash in lieu of any fraction of a share, to the Holder and register such issued
shares of Warrant Stock on the books of the Company as instructed by the Holder in the Exercise Notice. The issued shares of Warrant Stock
will be delivered by crediting the account of the Holder’s prime broker (as specified by the Holder to the Company) with the Depository
Trust Company (“DTC”) through its Deposit/Withdrawal At Custodian (“DWAC”)
system, whereby the Holder’s prime broker shall initiate a DWAC transaction no later than 4:00 p.m. Eastern Standard Time on the
third Trading Day following the Exercise Date using its DTC participant identification number, and released by Continental Stock Transfer
& Trust Company, the Company’s transfer agent (or any successor transfer agent of the Company) (the “Transfer
Agent”), at the Company’s direction. The Holder shall direct the broker-dealer at which the account or accounts
to be credited with the issued shares of Warrant Stock are maintained, which broker/dealer shall be a DTC participant, to initiate a transaction
through the DWAC system, instructing the Transfer Agent to credit such account or accounts with such shares of Warrant Stock. Such DWAC
instruction shall indicate the settlement date for the deposit of such shares of Warrant Stock, which shall be the Exercise Date. The
Company shall direct the Transfer Agent to credit the Holder’s account or accounts with such shares of Warrant Stock pursuant to
the information contained in the DWAC instruction. This Warrant shall be deemed to have been exercised and such shares of Warrant Stock
shall be deemed to have been issued, and the Holder or any other Person so designated to be named therein shall be deemed to have become
a holder of record of such shares of Warrant Stock for all purposes, as of the Exercise Date.

 

    6

     

    

 

(c) Subject
to Article 5 hereof, payment of the Warrant Price shall be made at the option of the Holder by one or more of the following methods: (i)
by delivery of a certified or official bank check or by wire transfer of immediately available funds in the amount of such Warrant Price
payable to the order of the Company, (ii) by instructing the Company to withhold a number of shares of Warrant Stock then issuable upon
exercise of this Warrant with an aggregate Fair Market Value equal to such Warrant Price, (iii) by surrendering to the Company shares
of Common Stock previously acquired by the Holder with an aggregate Fair Market Value equal to such Warrant Price, or (iv) any combination
of the foregoing. In the event of any withholding of Warrant Stock or surrender of Common Stock pursuant to clause (ii), (iii) or (iv)
of this Section 2.1(c) where the number of shares whose Fair Market Value is equal to the Warrant Price is not a whole number, the number
of shares withheld by or surrendered to the Company shall be rounded up to the nearest whole share and the Company shall make a cash payment
to the Holder based on the incremental fraction of a share being so withheld by or surrendered to the Company in an amount determined
in accordance with Section 2.3 hereof. The Holder will receive fully paid and nonassessable shares of Warrant Stock upon any exercise
of this Warrant.

 

(d) If
this Warrant shall have been exercised in part, the Company shall, at the time of delivery of the shares of Warrant Stock being issued
in accordance with Section 2.1(c) hereof, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased
shares of Warrant Stock called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.

 

(e) Subject
to Section 2.1(d) hereof, the Warrant delivered for exercise, and properly exercised by the Holder, in accordance with Sections 2.1(a)-(c)
and Article 5 hereof shall be canceled by the Company.

 

2.2 Payment
of Taxes. All shares of Warrant Stock issuable upon the exercise of this Warrant pursuant to the terms hereof shall be validly issued,
fully paid and nonassessable, issued without violation of any preemptive or similar rights of any stockholder of the Company and free
and clear of all Liens. The Company shall pay all expenses in connection with, and all taxes and other governmental charges that may be
imposed with respect to, the issue or delivery thereof.

 

2.3 Fractional
Shares. The Company shall not be required to issue a fractional share of Warrant Stock upon exercise of the Warrant. As to any fraction
of a share that the Holder of the Warrant, the rights under which are exercised in the same transaction, would otherwise be entitled to
purchase upon such exercise, the Company shall pay to the Holder an amount in cash equal to such fraction multiplied by the Fair Market
Value of one share of Common Stock on the Exercise Date.

 

    7

     

    

 

		3.	TRANSFER, DIVISION AND COMBINATION

 

3.1 Transfer.
Upon compliance with the provisions of this Section 3.1, each transfer of this Warrant and all rights hereunder, in whole or in part,
shall be registered on the books of the Company to be maintained for such purpose, upon surrender of this Warrant at the Designated Office
and compliance with the terms hereof, together with a written assignment of this Warrant in the form of Annex B attached hereto
duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes described in Section 2.2 hereof in
connection with the making of such transfer. Upon such compliance, surrender and delivery and, if required, such payment, the Company
shall execute and deliver a new Warrant in the name of the assignee or assignees and in the denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned and this Warrant shall
promptly be cancelled.

 

3.2 Mutilation
or Loss. Upon receipt by the Company from the Holder of evidence reasonably satisfactory to it of the loss, theft, destruction or
mutilation of this Warrant and an indemnity reasonably satisfactory to it (it being understood that the written indemnification agreement
of or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender and cancellation hereof,
the Company will execute and deliver in lieu hereof a new Warrant of like tenor to the Holder; provided, however, that,
in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.

 

3.3 Division
and Combination. Subject to compliance with the applicable provisions of this Warrant, this Warrant may be divided or, following such
division, combined with other Warrants upon presentation hereof at the Designated Office, together with a written notice specifying the
names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with
the applicable provisions of this Warrant as to any transfer which may be involved in such division or combination, the Company shall
execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such
notice.

 

3.4 Expenses.
The Company shall prepare, issue and deliver at its own expense any new Warrant or Warrants required to be issued hereunder.

 

3.5 Maintenance
of Books. The Company agrees to maintain, at the Designated Office, books for the registration and transfer of the Warrants.

 

    8

     

    

 

3.6 Registration
of Warrant Stock. Any issuance of shares of Common Stock pursuant to Section 2.1 of this Warrant (collectively, the “Issuances”)
shall be made pursuant to (i) an effective Registration Statement on Form S-3, No. 257159, including all amendments thereto, the exhibits
and any schedules thereto, the documents otherwise deemed to be a part thereof or included therein or any immediately succeeding registration
statement that is filed under the Securities Act on Form S-3 and immediately becomes effective (the “Registration Statement”)
filed by the Company with the Commission in conformity with the Securities Act under the Rules and Regulations of the Commission, including
the prospectus contained therein (the “Base Prospectus”) and (ii) a final prospectus supplement filed with the Commission
and delivered to the Holder (a “Prospectus Supplement” and, together with the Base Prospectus, a “Prospectus”)
containing amended and/or certain supplemental information regarding the Common Stock and terms of the Issuances. If the Company has filed
one or more abbreviated registration statements to register additional shares of Common Stock pursuant to Rule 462(b) under the Rules
and Regulations (each a “Rule 462(b) Registration Statement”), then any reference herein to the term “Registration
Statement” shall also be deemed to include any such Rule 462(b) Registration Statement.

 

(i) The
Company shall use reasonable best efforts to keep the Registration Statement effective until the earliest date as of which there are no
remaining Issuances, and if, at any time from the date hereof, the Company is not eligible to issue any Common Stock or Warrants pursuant
to the Registration Statement, the Company shall use reasonable best efforts to file and make effective a replacement Registration Statement
as soon as practicable. If the Registration Statement has been outstanding for at least three (3) years, at the end of the third year,
the Company shall file a new Registration Statement covering Issuances, and if at any time when the Company is required to re-evaluate
its eligibility to use Form S-3, the Company determines that it is not eligible to use Form S-3, the Company shall use its reasonable
best efforts to refile the Registration Statement on Form S-1 if such form is available (or on such other form as may be available if
Form S-1 is not available), and keep such registration statement effective during the period during which such registration statement
is required to be otherwise kept effective under this Section 3.6(i).

 

(ii) For
the avoidance of doubt, the Company acknowledges and agrees that no Issuances shall be made pursuant to any prospectus or prospectus supplement
other than a Prospectus or any replacement Registration Statement required by this Section 3.6. The Company represents and warrants that,
as of the Effective Date, the Securities Act and Rules and Regulations permit the Company to offer and issue $205,000,000 worth of shares
of Common Stock and other securities listed in the Registration Statement pursuant to the Registration Statement, of which as of July
1, 2021, approximately $147,500,000 remains available. The Company represents and warrants that the Registration Statement complied when
it became effective, complies on the Effective Date and shall comply on the Original Issue Date and on each Exercise Date and any later
date upon which shares of Common Stock are received pursuant to this Agreement or a Warrant, in each case, in all material respects with
the requirements of Form S-3 under the Securities Act. The Company represents and warrants that no order preventing or suspending the
use of the Prospectus has been issued by the Commission, and no stop order suspending the effectiveness of the Registration Statement
or any post-effective amendment thereto has been issued, and no proceedings for that purpose have been instituted or, to the Company’s
knowledge, are threatened by the Commission. The Company represents and warrants that neither the Registration Statement nor the Prospectus
shall, as of the Effective Date, the Original Issue Date or any Exercise Date or any later date on which shares of Common Stock are issued
to the Holder under the Prospectus, contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading.

 

    9

     

    

 

(iii) The
Company shall as soon as practicable notify the Holder of (A) the issuance by the Commission of any stop order suspending the effectiveness
of any registration statement or the initiation of any proceedings for that purpose, (B) the receipt by the Company or its counsel of
any notification with respect to the suspension of the qualification of shares of Common Stock or Warrants for sale in any jurisdiction
or the initiation or threatening of any proceeding for such purpose, and (C) the effectiveness of each registration statement filed hereunder.

 

(iv) The
Company shall use reasonable best efforts to cause the Warrant Stock when issued to be listed or quoted on each Trading Market on which
the Common Stock is then listed or quoted.

 

(v) The
Company shall use its reasonable best efforts to timely file its SEC Reports (or, if the Company is not required to file such reports,
it will, upon the request of the Holder, make publicly available such information as necessary to permit sales pursuant to Rule 144 under
the Securities Act), and the Company shall use reasonable best efforts to take such further action as the Holder may reasonably request,
in each case to the extent required from time to time to enable the Holder to, if permitted by the terms of an applicable Warrant, sell
such Warrant or its underlying Warrant Stock without registration under the Securities Act within the limitation of the exemptions provided
by (A) Rule 144 under the Securities Act, as such rule may be amended from time to time, or (B) any successor rule or regulation hereafter
adopted by the Commission. Upon the written request of the Holder, the Company shall deliver to the Holder a written statement that it
has complied with such requirements.

 

		4.	ANTIDILUTION PROVISIONS

 

The number of shares of Warrant
Stock for which this Warrant is exercisable and the Exercise Price shall be subject to adjustment from time to time as set forth in this
Article 4.

 

4.1 Upon
Issuance of Common Stock. If the Company shall, at any time or from time to time after the Original Issue Date, issue any shares of
Common Stock, options to purchase or rights to subscribe for Common Stock, securities by their terms convertible into or exchangeable
for Common Stock, or options to purchase or rights to subscribe for such convertible or exchangeable securities without consideration
or for consideration per share less than the greater of (x) the Exercise Price in effect immediately prior to the issuance of such Common
Stock or securities and (y) the Fair Market Value per share of the Common Stock immediately prior to such issuance (the greater of (x)
and (y), the “Reference Price”), then such Exercise Price shall forthwith be lowered to a price equal to the price
obtained by multiplying:

 

(i) the
Exercise Price in effect immediately prior to the issuance of such Common Stock, options, rights or securities by

 

(ii) a
fraction of which (x) the numerator shall be the sum of (i) the number of shares of Common Stock Outstanding immediately prior to such
issuance and (ii) the number of additional shares of Common Stock which the aggregate consideration for the number of shares of Common
Stock so offered would purchase at the Reference Price and (y) the denominator shall be the number of shares of Common Stock Outstanding
immediately after such issuance.

 

    10

     

    

 

4.2 Upon
Acquisition of Common Stock. If the Company or any Subsidiary shall, at any time or from time to time after the Original Issue Date,
directly or indirectly, redeem, purchase or otherwise acquire any shares of Common Stock, options to purchase or rights to subscribe for
Common Stock, securities by their terms convertible into or exchangeable for Common Stock, or options to purchase or rights to subscribe
for such convertible or exchangeable securities, for a consideration per share (plus, in the case of such options, rights, or securities,
the additional consideration required to be paid to the Company upon exercise, conversion or exchange) greater than the Fair Market Value
per share of Common Stock immediately prior to the earlier of (x) the announcement of such event or (y) such event, then the Exercise
Price shall forthwith be lowered to a price equal to the price obtained by multiplying:

 

(i) the
Exercise Price in effect immediately prior to such event by

 

(ii) a
fraction:

 

		(A)	the numerator of which is (1) the product of (a) the number of shares of Common Stock Outstanding and
(b) the Fair Market Value per share of Common Stock, in each case immediately prior to such event, minus (2) the aggregate consideration
paid by the Company in such event (plus, in the case of such options, rights, or convertible or exchangeable securities, the aggregate
additional consideration required to be paid to the Company upon exercise, conversion or exchange), and

 

		(B)	the denominator of which is the product of (1) the number of shares of Common Stock Outstanding immediately
after such event and (2) the Fair Market Value per share of Common Stock immediately prior to such event.

 

4.3 Provisions
Applicable to Adjustments. For the purposes of any adjustment of the Exercise Price pursuant to Section 4.1 or 4.2 hereof, the following
provisions shall be applicable:

 

(i) In
the case of the issuance of Common Stock, options to purchase or rights to subscribe for Common Stock, securities by their terms convertible
into or exchangeable for Common Stock, or options to purchase or rights to subscribe for such convertible or exchangeable securities for
a consideration in whole or in part other than cash, the consideration other than cash shall be deemed to be the Fair Market Value of
the non-cash consideration.

 

    11

     

    

 

(ii) In
the case of the issuance of options to purchase or rights to subscribe for Common Stock, securities by their terms convertible into or
exchangeable for Common Stock, or options to purchase or rights to subscribe for such convertible or exchangeable securities:

 

		(A)	the aggregate maximum number of shares of Common Stock that potentially may be deliverable upon exercise
of such options to purchase or rights to subscribe for Common Stock at any time during the term thereof shall be deemed to have been issued
at the time such options or rights were issued and for a consideration equal to the consideration (determined in the manner provided in
subparagraph (i) above), if any, received by the Company upon the issuance of such options or rights plus the minimum purchase price provided
in such options or rights for the Common Stock covered thereby;

 

		(B)	the aggregate maximum number of shares of Common Stock that potentially may be deliverable upon conversion
of or in exchange for any such convertible or exchangeable securities or upon the exercise of options to purchase or rights to subscribe
for such convertible or exchangeable securities and subsequent conversion or exchange thereof at any time during the term thereof shall
be deemed to have been issued at the time such securities, options, or rights were issued and for a consideration equal to the consideration
received by the Company for any such securities and related options or rights (excluding any cash received on account of accrued interest
or accrued dividends), plus the additional consideration, if any, to be received by the Company upon the conversion or exchange of such
securities or the exercise of any related options or rights (the consideration in each case to be determined in the manner provided in
paragraph (i) above);

 

		(C)	on any increase in the number of shares or decrease in the effective exercise or conversion price of Common
Stock deliverable upon exercise of any such options, rights or securities or conversions of or exchanges of such securities, including
any change resulting from the anti-dilution provisions thereof, the Exercise Price shall forthwith be readjusted to such Exercise Price
as would have been obtained had the adjustment made upon the issuance of such options, rights or securities not converted prior to such
change or options or rights related to such securities not converted prior to such change been made upon the basis of such change; and

 

		(D)	no further adjustment of the Exercise Price adjusted upon the issuance of any such options, rights, convertible
securities or exchangeable securities shall be made as a result of the actual issuance of Common Stock on the exercise of any such rights
or options or any conversion or exchange of any such securities.

 

    12

     

    

 

4.4 Upon
Stock Dividends, Subdivisions or Splits. If, at any time after the Original Issue Date, the number of shares of Common Stock Outstanding
is increased by a stock dividend payable in shares of Common Stock or by a subdivision or split-up of shares of Common Stock, then, following
the record date for the determination of holders of Common Stock entitled to receive such stock dividend, or to be affected by such subdivision
or split-up, the Exercise Price shall be appropriately decreased by multiplying each price by a fraction, the numerator of which is the
number of shares of Common Stock Outstanding immediately prior to such increase and the denominator of which is the number of shares of
Common Stock Outstanding immediately after such increase in Outstanding shares.

 

4.5 Upon
Combinations or Reverse Stock Splits. If, at any time after the Original Issue Date, the number of shares of Common Stock Outstanding
is decreased by a combination or reverse stock split of the Outstanding shares of Common Stock into a smaller number of shares of Common
Stock, then, following the record date to determine shares affected by such combination or reverse stock split, the Exercise Price shall
be appropriately increased by multiplying each price by a fraction, the numerator of which is the number of shares of Common Stock Outstanding
immediately prior to such decrease and the denominator of which is the number of shares of Common Stock Outstanding immediately after
such decrease in Outstanding shares.

 

4.6 Upon
Reclassifications, Reorganizations, Consolidations, Mergers or Dispositions of Assets. In the event of any capital reorganization
of the Company, any reclassification of the capital stock of the Company (other than a change in par value or from par value to no par
value or from no par value to par value or as a result of a stock dividend or subdivision, stock-split, reverse stock-split or combination
of shares), any consolidation or merger of the Company with or into another Person (where the Company is not the surviving Person or where
there is a change in or distribution with respect to the Common Stock) or sale, transfer or other disposition of all or substantially
all of the Company’s property, assets or business to another Person, each Warrant shall after such reorganization, reclassification,
consolidation, merger or disposition of assets be exercisable for the kind and number of shares of stock or other securities or property
of the Company or of the successor Person (if other than the Company) resulting from such reorganization, reclassification, consolidation,
merger or disposition of assets, if any, to which the holder of the number of shares of Common Stock deliverable (immediately prior to
the time of such reorganization, reclassification, consolidation, merger or disposition of assets) upon exercise of such Warrant would
have been entitled upon such reorganization, reclassification, consolidation, merger or disposition of assets (without taking into account
any limitations or restrictions on the exercisability of this Warrant); and, in such case, appropriate adjustment (in form and substance
satisfactory to the Holder) shall be made with respect to the Holder’s rights under this Warrant to insure that the provisions of
Article 4 hereof shall thereafter be applicable, as nearly as possible, to this Warrant in relation to any shares of stock, securities
or assets thereafter acquirable upon exercise of this Warrant. The Company shall not effect any such reorganization, reclassification,
consolidation, merger or disposition of assets unless, prior to the consummation thereof, the successor Person (if other than the Company)
resulting from such reorganization, reclassification, consolidation, merger or disposition of assets, shall assume, by written instrument,
(i) the obligation to deliver to the Holders of the Warrant such shares of stock, securities or assets, which, in accordance with the
foregoing provisions of this Section 4.6, the Holders shall be entitled to receive upon such conversion and (ii) the obligations of the
Company pursuant to the provisions of Section 3.6. The provisions of this Section 4.6 shall similarly apply to successive reorganizations,
reclassifications, consolidations, mergers or dispositions of assets.

 

    13

     

    

 

4.7 Other
Anti-Dilution Provisions. If the Company has issued or issues any securities of the Company to a financial institution, lender, other
credit provider, leasing company or other lessor in connection with the provisions of any financing or lending agreements, containing
provisions (including, without limitation, anti-dilution and registration rights) which are more favorable than those set forth herein,
the Company will make such provisions (or any more favorable portion thereof) available to the Holder and will enter into amendments necessary
to confer such rights on the Holder. Notwithstanding the foregoing, any adjustment to the Exercise Price or number of shares of Warrant
Stock shall be made only pursuant to and in accordance with Article 4 of this Warrant.

 

4.8 Appraisal
Procedure. In any case in which the provisions of this Article 4 shall necessitate that the Appraisal Procedure be utilized for purposes
of determining an adjustment to the Exercise Price, the Company may defer, until the completion of the Appraisal Procedure and the determination
of the adjustment, (i) issuing to the Holder of any Warrant exercised after the date of the event that requires the adjustment and before
completion of the Appraisal Procedure and the determination of the adjustment, the shares of capital stock issuable upon such exercise
by reason of the adjustment required by such event and issuing to the Holder only the shares of capital stock issuable upon such exercise
before giving effect to such adjustment and (ii) paying to the Holder any amount in cash in lieu of a fractional share of capital stock
pursuant to Section 2.3 above; provided, however, that the Company shall deliver to the Holder an appropriate instrument
or due bills evidencing the Holder’s right to receive such additional shares or such cash.

 

4.9 Adjustment
of Number of Shares Purchasable. Upon any adjustment of the Exercise Price as provided in Section 4.1, 4.2, 4.4, 4.5 and 4.6, the
Holders of the Warrants shall thereafter be entitled to purchase upon the exercise thereof, at the Exercise Price resulting from such
adjustment, the number of shares of Warrant Stock (calculated to the nearest 1/100th of a share) obtained by multiplying the Exercise
Price in effect immediately prior to such adjustment by the number of shares of Warrant Stock issuable on the exercise hereof immediately
prior to such adjustment and dividing the product thereof by the Exercise Price resulting from such adjustment.

 

4.10 Increase
of Number of Shares Purchasable. After giving effect to all other provisions in this Article 4 other than this Section 4.10, the number
of shares of Warrant Stock purchasable upon exercise of this Warrant shall be increased when the Exercise Price is adjusted to an amount
below the then-existing par value of the Warrant Stock, including successive adjustments to the Exercise Price to an amount further below
the then-existing par value. The number of additional shares purchasable upon exercise of this Warrant shall be equal to the number obtained
by dividing:

 

(i) The
product of (A) the number of shares purchasable upon exercise of the Warrant before application of this Section 4.10 and (B) the difference
between the then-existing par value per share of Warrant Stock minus the adjusted Exercise Price, by

 

(ii) The
difference between the Fair Market Value of the Common Stock on the Exercise Date minus the then-existing par value per share of Warrant
Stock.

 

    14

     

    

 

Concurrently with the foregoing adjustment to
the number of additional shares purchasable upon exercise of this Warrant, the Exercise Price shall be adjusted to be the then-existing
par value of the Warrant Stock.

 

4.11 Form
of Warrants. Irrespective of any adjustments of the number of shares of Warrant Stock purchasable or of the Exercise Price, the Warrant
theretofore or thereafter issued may continue to express the same price and number and kind of shares as are stated in the Warrant issued
on the Original Issue Date.

 

4.12 Changes
in Securities. Notwithstanding any provision in this Article 4 to the contrary and without limitation to any other provision contained
in this Article 4, in the event any securities of the Company are amended, modified or otherwise altered by operation of this Article
4’s terms or otherwise in any manner whatsoever (including through the anti-dilution provisions thereof) that results in (i) the
reduction of the effective exercise, conversion or exchange price of such securities payable upon the exercise for, or conversion or exchange
into, Common Stock or other securities exercisable for, or convertible or exchangeable into, Common Stock and/or (ii) such securities
becoming exercisable for, or convertible or exchangeable into (A) more shares or dollar amount of such securities which are, in turn exercisable
for, or convertible or exchangeable into, Common Stock, or (B) more shares of Common Stock, then such amendment, modification or other
alteration shall be treated for purposes of Article 4 as if the securities which have been amended, modified or altered have been terminated
and new securities have been issued with the amended or modified terms. The Company shall make all necessary adjustments (including successive
adjustments if required) to the Exercise Price in accordance with this Article 4, but in no event shall the Exercise Price be greater
than it was immediately prior to the application of this Section 4.12 to the amendment, modification or alteration in question.

 

4.13 Maximum
Exercise Price. Except as provided in Section 4.5 above, at no time shall the Exercise Price per share of Warrant Stock exceed the
amount set forth in the preamble of this Warrant.

 

4.14 Exceptions.
Notwithstanding anything to the contrary, Article 4 hereof shall not apply to (i) (A) the issuance and exercise of options to purchase
shares of Common Stock and (B) the issuance of shares of Common Stock, in each case of the foregoing clause (A) and (B), as made to eligible
recipients pursuant to any equity incentive plan duly adopted by the board of directors of the Company in the ordinary course of business,
or (ii) any issuance of shares of Common Stock upon conversion of the Company’s convertible debt securities outstanding as of the
Effective Date.

 

4.15 Notice
of Adjustment of Exercise Price. Whenever the number of shares of Common Stock for which this Warrant is exercisable or the Exercise
Price is adjusted as provided under Article 4 hereof:

 

(i) the
Company shall compute the adjusted Exercise Price in accordance with this Article 4 and shall prepare a certificate signed by the treasurer
or chief financial officer of the Company setting forth the adjusted Exercise Price and showing in reasonable detail the facts upon which
such adjustment is based, and such certificate shall forthwith be filed at the Designated Office; and

 

    15

     

    

 

(ii) a
notice stating that the Exercise Price has been adjusted and setting forth the adjusted Exercise Price shall forthwith be prepared by
the Company, and as soon as practicable after it is prepared, such notice shall be mailed by the Company at its expense to the Holder
at its last address as it shall appear in the warrant register. If the Board of Directors of the Company makes any determination of Fair
Market Value for purposes of determining such proposed adjustment, then, within thirty (30) days of the Holder’s receipt of such
notice, the Holder shall have the right to use the Appraisal Procedure to determine Fair Market Value with respect to the entire proposed
adjustment.

 

4.16 Independent
Application. Except as otherwise provided herein, all sections of this Article 4 are intended to operate independently of one another
(but without duplication). If an event occurs that requires the application of more than one section of this Article 4, all applicable
sections shall be given independent effect without duplication.

 

		5.	BENEFICIAL OWNERSHIP LIMITS; ISSUANCE CAP

 

5.1 Beneficial
Ownership Limitation.

 

(a) Notwithstanding
anything to the contrary contained herein, the Holder shall not receive shares of Warrant Stock upon exercise of the Warrant to the extent
(but only to the extent) that such exercise or receipt would cause the Holder Group to become, directly or indirectly, a beneficial owner
of a number of shares of Common Stock that exceeds the Maximum Percentage of Common Stock Outstanding as of the Exercise Date (the “Beneficial
Ownership Limitation“). The Beneficial Ownership Limitation (i) may be increased or decreased, in the Holder’s
sole discretion, upon 61 days’ written notice to the Company by the Holder, provided, however, that in no event shall
the Holder increase such Beneficial Ownership Limitation to raise the Maximum Percentage in excess of 19.99% as of any date of shares
of Common Stock Outstanding from the date hereof through the Expiration Date and (ii) shall automatically be increased to a Maximum Percentage
of 19.99% on the date that is 15 days prior to the Expiration Date.

 

(b) At
the time of delivery of any Exercise Notice, the Holder shall notify the Company if, and only if, a Holder Group would beneficially own
a number of shares of Common Stock in excess of the Beneficial Ownership Limitation upon giving effect to such Exercise Notice. For the
avoidance of doubt, upon any failure by the Holder to deliver such notice, any subsequent purported delivery in such instance of Warrant
Stock shall be void and have no effect pursuant to Section 5.1(c) hereof.

 

    16

     

    

 

(c) Any
purported delivery of Warrant Stock pursuant to Section 2.1(b) hereof, and any purported payment by the Holder of the Warrant Price pursuant
to Section 2.1(a) and 2.1(c) hereof, in connection with the exercise of the Warrant shall be void and have no effect to the extent (but
only to the extent) that such delivery would violate the Beneficial Ownership Limitation. If any delivery of Warrant Stock owed to the
Holder following exercise of the Warrant is not made, in whole or in part, as a result of the Beneficial Ownership Limitation, the Company’s
obligation to make such delivery shall not be extinguished and the Company shall deliver such Warrant Stock as promptly as practicable
after the Holder gives written notice to the Company that such delivery would not violate the Beneficial Ownership Limitation (the “Delivery
Notice”), provided, however, that (i) the Holder shall be deemed to have exercised this Warrant in respect of
any such delayed Warrant Stock (other than at the Expiration Date) as of the date of the applicable Delivery Notice and (ii) for
the avoidance of doubt, Article 4 hereof and Article 10 hereof shall remain in full force and effect for such period of delay, and provided,
further, however, that at the Expiration Date and in accordance with the deemed Exercise Notice under Section 2.1(a) hereof,
if, without giving effect to the Beneficial Ownership Limitation, the Warrant would be exercisable for any Warrant Stock, (i) the Holder
shall be entitled to receive from the Company any such remaining Warrant Stock under the terms of this Warrant until such time as the
Beneficial Ownership Limitation would not prohibit such delivery (such Warrant Stock at the Expiration Date, the “Expiration
Warrant Stock”), (ii) the Holder shall be deemed to have exercised this Warrant in respect of all such Expiration Warrant Stock
as of the date of the Holder’s receipt from the Company of the Expiration Warrant Stock (which exercise shall be subject to Article
4 hereof but not be subject to Sections 4.1 through 4.3 hereof) and (iii) for the avoidance of doubt, Article 10 hereof shall remain
in full force and effect for the period until the delivery of the Expiration Warrant Stock.

 

(d) For
purposes of this Section 5.1, (i) the term “Maximum Percentage“ shall mean
4.99%; provided, however, that if at any time after the date hereof the Holder Group beneficially owns in excess of 4.99%
of the Outstanding Common Stock (excluding any Common Stock that could be acquired by exercise of this Warrant), then the Maximum Percentage
shall automatically increase to 9.99% so long as any Holder Group owns in excess of 4.99% of such Common Stock (and shall, for the avoidance
of doubt, automatically decrease to 4.99% upon the time when no Holder Group beneficially owns in excess of 4.99% of such Outstanding
Common Stock); and (ii) the term “Holder Group“ shall mean any group in respect
of Common Stock, where “group” has the meaning established under Section 13(d) of the Exchange Act and the rules promulgated
thereunder, if the Holder or any other Person having beneficial ownership of Common Stock beneficially owned by the Holder is a member
of such group. In determining the number of shares of Common Stock Outstanding for purposes of this Section 5.1 and the number of shares
that the Holder may at any time acquire pursuant to the Beneficial Ownership Limitation and the other terms of this Section 5.1, the Holder
shall give effect to the last sentence of Rule 13d-3(d)(1)(i) as promulgated under the Exchange Act, and the Holder may rely on the number
of outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K or Quarterly Report
on Form 10-Q filed with the Commission, as the case may be, (y) a more recent public announcement by the Company or (z) a more recent
notice by the Company or its transfer agent to the Holder setting forth the number of shares of Common Stock then outstanding. Upon written
or oral request of the Holder, the Company shall, within two (2) Business Days of such request, confirm orally and in writing to the Holder
the number of shares of Common Stock then Outstanding. The provisions of this Section 5.1 shall be construed, corrected and implemented
in a manner so as to effectuate the intended Beneficial Ownership Limitation.

 

    17

     

    

 

5.2 Issuance
Cap. Unless Stockholder Approval has been previously obtained, in the event that any issuance of Warrant Stock upon the exercise of
this Warrant would, together with any other issuance of shares of Common Stock by the Company to any holder of any Warrant that would
be aggregated with such proposed issuance under this Warrant for determining whether such issuances collectively would require approval
by a vote of Company stockholders under the applicable listing rules of the Nasdaq Global Market, any successor stock exchange operated
by the NASDAQ Stock Market LLC or any successor thereto (such other issuances the “Related
Issuances“), exceed 19.99% of the Common Stock Outstanding on January 2, 2021 (the “Aggregation Date”),
the Holder shall receive only a number of shares of Common Stock, rounded down to the nearest whole number, equal to (A) the maximum
number of shares of Common Stock which could be issued to the Holder and any other recipients of any then-proposed Related Issuances in
the aggregate without the Related Issuances exceeding 19.99% of the Common Stock Outstanding on the Aggregation Date multiplied by a ratio
equal to (B) (1) the number of shares of Common Stock that would be otherwise received by the Holder under this Warrant divided by
(2) the number of all of the shares of Common Stock that would be otherwise received by the Holder under this Warrant and the recipients
of any then-proposed Related Issuances in the aggregate. To the extent the Holder is entitled to receive from the Company a number of
shares of Warrant Stock reduced by this Section 5.2, the Company shall pay to the Holder, in satisfaction of the Company’s obligation
to deliver such Warrant Stock, a cash amount equivalent to the Fair Market Value, determined as of the Exercise Date, of the number of
shares of Warrant Stock by which such exercise was reduced within three (3) Business Days of the Exercise Date.

 

		6.	NO IMPAIRMENT; REGULATORY COMPLIANCE AND COOPERATION

 

6.1 No
Impairment. The Company shall not by any action, including, without limitation, amending its charter documents or through any reorganization,
reclassification, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other similar voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in
the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of the
Holder against impairment. Without limiting the generality of the foregoing, the Company shall take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Warrant Stock upon the exercise
of this Warrant, free and clear of all Liens, and shall use its best efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under
this Warrant. The Company shall not take any action, enter into any transaction or suffer to exist any event, action or state of facts
that would cause the Exercise Price to be adjusted below the then existing par value of Common Stock (unless the Common Stock is changed
to capital stock with no par value); provided, however, that nothing herein will prevent the operation of any other provision
of this Warrant, including the anti-dilution provisions of Article 4 hereof.

 

6.2 No
Dilution. If any event shall occur as to which the provisions of Article 4 hereof are not strictly applicable but the failure to make
any adjustment would adversely affect the purchase rights represented by the Warrant in accordance with the essential intent and principles
of such Article (including, without limitation, the issuance of securities other than Common Stock which have the right to participate
in distributions to the holders of Common Stock, the granting of “phantom stock” rights or “stock appreciation rights”),
then, in each such case, the Company shall, upon the request of any Holder, appoint an investment banking firm of recognized national
standing, or any other financial expert that does not (or whose directors, officers, employees, Affiliates or stockholders do not) have
a direct or material indirect financial interest in the Company or any of its Subsidiaries, who has not been, and, at the time it is called
upon to give independent financial advice to the Company, is not (and none of its directors, officers, employees, Affiliates or stockholders
are) a promoter, director or officer of the Company or any of its Subsidiaries, which shall give their opinion upon the adjustment, if
any, on a basis consistent with the essential intent and principles established in Article 4 hereof, necessary to preserve, without dilution,
the purchase rights, represented by this Warrant. Prior to such determination by such investment banking firm, the Company and the requesting
Holder(s), respectively, shall specify the amount, if any, of the adjustment that such party has determined in good faith to be appropriate.
The adjustment determined by the investment banking firm shall be within the range of the adjustments thus proposed by the parties, and
the costs and fees of such investment banking firm shall be allocated proportionately between the Company, on one hand, and the Holder,
on the other, based on the respective differences between the amount of the adjustment as determined by such investment banking firm and
the amounts of such adjustment proposed by the Company and the Holder. Upon receipt of such opinion, the Company will promptly mail a
copy thereof to the holders of the Warrants and shall make the adjustments described therein.

 

    18

     

    

 

6.3 Other
Agreements. The Company is not a party to or bound in any manner under, and covenants that it will not enter into at any time after
the date hereof, any agreement or contract (whether written or oral) with respect to any of its securities which prevents the Company
from complying in any respect with the rights granted by the Company hereunder.

 

6.4 Antitrust
Notification. If the Holder determines, in its sole judgment upon the advice of counsel, that an exercise of this Warrant pursuant
to the terms hereof would be subject to the provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR
Act”), the Company shall file, within seven (7) Business Days after receiving notice from the Holder of the applicability of
the HSR Act and a request to so file, with the United States Federal Trade Commission (the “FTC”) and the United States
Department of Justice (the “DOJ”) the notification and report form and any supplemental information required to be
filed by it pursuant to the HSR Act in connection with the exercise of this Warrant. Any such notification and report form and supplemental
information will be in full compliance with the requirements of the HSR Act. The Company will furnish to the Holder promptly (but in no
event more than five (5) business days) such information and assistance as such holder may reasonably request in connection with the preparation
of any filing or submission required to be filed by the Holder under the HSR Act. The Company shall respond promptly after receiving any
inquiries or requests for additional information from the FTC or the DOJ (and in no event more than three (3) business days after receipt
of such inquiry or request). The Company shall keep the Holder apprised periodically and at the Holder's request of the status of any
communications with, and any inquiries or requests for additional information from, the FTC or the DOJ. The Company shall bear all filing
or other fees required to be paid by the Company under the HSR Act or any other applicable law in connection with such filings and all
costs and expenses (including, without limitation, reasonable attorneys' fees and expenses) incurred by the Company in connection with
the preparation of such filings and responses to inquiries or requests. The Company shall also bear 50% of all filing or other fees required
to be paid by the Holder (or the “ultimate parent entity” of the Holder, if any) under the HSR Act or any other applicable
law in connection with such filings and 50% of all costs and expenses (including, without limitation, reasonable attorneys' fees and expenses)
incurred by the Holder in connection with the preparation of such filings and responses to inquiries or requests, and the Holder shall
bear the remaining 50% of such fees, costs and expenses. In the event that this Section 6.4 is applicable to any exercise of this Warrant,
the issuance to the Holder of the applicable Warrant Stock, and the payment by the Holder of the Warrant Price therefor, shall be subject
to the expiration or earlier termination of the waiting period under the HSR Act (with the Exercise Date being deemed to be the date immediately
following the date of such expiration or early termination).

 

    19

     

    

 

		7.	RESERVATION AND AUTHORIZATION OF COMMON STOCK

 

7.1 Reservation.
The Company shall at all times reserve and keep available for issuance upon the exercise of the Warrant such number of its authorized
but unissued shares of Common Stock as will be required for issuance of the Warrant Stock. All shares of Warrant Stock issuable pursuant
to the terms hereof, when issued upon exercise of this Warrant with payment therefor in accordance with the terms hereof, shall be duly
and validly issued and fully paid and nonassessable, not subject to preemptive rights and shall be free and clear of all Liens. Before
taking any action that would result in an adjustment in the number of shares of Warrant Stock for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction over such action. If any shares of Warrant Stock required to be reserved
for issuance upon exercise of the Warrant require registration or qualification with any Governmental Authority under any federal or state
law (including the Securities Act and state securities laws) before such shares may be so issued, the Company will use its commercially
reasonable efforts to register and qualify such shares as soon as practicable and at its expense.

 

7.2 Corporate
Action. Before taking any action that would cause an adjustment reducing the Exercise Price below the then-par value (if any) of the
shares of Warrant Stock deliverable upon exercise of the Warrant or that would cause the number of shares of Warrant Stock issuable upon
exercise of the Warrant to exceed (when taken together with all other Outstanding shares of Common Stock) the number of shares of Common
Stock that the Company is authorized to issue, the Company will take any corporate action that, in the opinion of its counsel, is necessary
in order that the Company may validly and legally issue the full number of fully paid and nonassessable shares of Warrant Stock issuable
upon exercise of the Warrant at such adjusted exercise price.

 

		8.	NOTICE OF CORPORATE ACTIONS; TAKING OF RECORD; TRANSFER BOOKS

 

8.1 Notices
of Corporate Actions.

 

In case:

 

(a) the
Company shall grant to the holders of its Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of
any class; or

 

(b) the
Company shall declare to the holders of its Common Stock any dividend or distribution; or

 

(c) of
any reclassification of the Common Stock (other than a subdivision or combination of the Outstanding shares of Common Stock), or of any
consolidation, merger or share exchange to which the Company is a party and for which approval of any stockholders of the Company is required,
or of the sale or transfer of all or substantially all of the assets of the Company; or

 

    20

     

    

 

(d) of
the voluntary or involuntary dissolution, liquidation or winding up of the Company;

 

(e) the
Company or any Subsidiary shall commence a tender offer for all or a portion of the Outstanding shares of Common Stock (or shall amend
any such tender offer to change the maximum number of shares being sought or the amount or type of consideration being offered therefor);
or

 

(f) the
Company or any Subsidiary takes any action or any event or circumstance occurs that impacts the rights of a Holder set forth herein or
in the Credit Agreement, as applicable;

 

then the Company shall cause to be filed at the
Designated Office, and shall cause to be mailed to the Holder at its last address as it shall appear in the warrant register, at least
30 days prior to the applicable record, effective or expiration date hereinafter specified, a notice stating (x) the date on which a record
is to be taken for the purpose of such dividend, distribution or granting of rights or warrants, or, if a record is not to be taken, the
date as of which the holders of Common Stock of record who will be entitled to such dividend, distribution, rights or warrants are to
be determined, (y) the date on which such reclassification, consolidation, merger, share exchange, sale, transfer, dissolution, liquidation
or winding up is expected to become effective, and the date as of which it is expected that holders of Common Stock of record shall be
entitled to exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, share exchange, sale, transfer, dissolution, liquidation or winding up, or (z) the date on which such tender offer commenced,
the date on which such tender offer is scheduled to expire unless extended, the consideration offered and the other material terms thereof
(or the material terms of the amendment thereto). Such notice shall also set forth such facts with respect thereto as shall be reasonably
necessary to indicate the effect of such action on the Exercise Price and the number and kind or class of shares or other securities or
property which shall be deliverable or purchasable upon the occurrence of such action or deliverable upon exercise of the Warrants. Neither
the failure to give any such notice nor any defect therein shall affect the legality or validity of any action described in clauses (a)
through (e) of this Section 8.1.

 

8.2 Taking
of Record. In the case of all dividends or other distributions by the Company to the holders of its Common Stock with respect to which
any provision hereof refers to the taking of a record of such holders, the Company will in each such case take such a record and will
take such record as of the close of business on a Business Day.

 

8.3 Closing
of Transfer Books. The Company shall not at any time close its stock transfer books or warrant transfer books so as to result in preventing
or delaying the exercise or transfer of any Warrant.

 

    21

     

    

 

		9.	OFFICE OF THE COMPANY

 

9.1 As
long as the Warrant remains outstanding, the Company shall maintain an office or agency, which may be the principal executive offices
of the Company (the “Designated Office“), where the Warrant may be presented
for exercise, registration of transfer, division or combination as provided in this Warrant. Such Designated Office shall initially be
the office of the Company at 550 South Hope Street, Suite 2850, Los Angeles, California 90071. The Company may from time to time change
the Designated Office to another office of the Company or its agent within the United States by notice given to any registered Holders
at least ten (10) Business Days prior to the effective date of such change.

 

		10.	DILUTION ADJUSTMENT

 

10.1 Dilution
Adjustment.

 

(a) In
the event that any dividends are declared or paid or any other distribution is made on or with respect to the Common Stock, the Holder
as of the record date established by the Board of Directors of the Company for such dividend or distribution on the Common Stock shall
be entitled to receive a fee (the “Dilution Adjustment”) in an amount (whether in the form of cash, securities or other property)
equal to the amount (and in the form) of the dividends or distribution that such Holder would have received had the Warrant been exercised
as of the date immediately prior to the record date for such dividend or distribution, such Dilution Adjustment to be payable on the same
payment date established by the Board of Directors of the Company for the payment of such dividend or distribution; provided, however,
that if the Company declares and pays a dividend or distribution on the Common Stock consisting in whole or in part of Common Stock, then
no such Dilution Adjustment shall be payable in respect of the Warrant on account of the portion of such dividend or distribution on the
Common Stock payable in Common Stock and in lieu thereof the applicable adjustment in Article 4 hereof shall apply. The record date for
any such Dilution Adjustment shall be the record date for the applicable dividend or distribution on the Common Stock, and any such Dilution
Adjustment shall be payable to the Persons in whose name the Warrant is registered at the close of business on the applicable record date.

 

(b) No
dividend shall be paid or declared on any share of Common Stock (other than dividends payable in Common Stock for which an adjustment
was made pursuant to Article 4 hereof), unless the Dilution Adjustment, payable in the same consideration and manner, is simultaneously
paid or provided for, as the case may be, in respect of this Warrant in an amount determined as set forth in this Section 10.1. For purposes
of this Warrant, the term “dividends” shall include any pro rata distribution by the Company, out of funds of the Company
legally available therefor, of cash, property, securities (including, but not limited to, rights, warrants or options and/or securities
in connection with a spin-off of the Company) or other property or assets to the holders of the Common Stock, whether or not paid out
of capital, surplus or earnings other than liquidation.

 

(c) Prior
to declaring any dividend or making any distribution on or with respect to shares of Common Stock, the Company shall take all prior corporate
action necessary to authorize the issuance of any securities payable as the Dilution Adjustment in respect of the Warrant.

 

    22

     

    

 

		11.	MISCELLANEOUS

 

11.1 No
Implied Waivers. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver
thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right,
power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by
law.

 

11.2 Notices.
All notices, requests, consents and other communications required or permitted hereunder shall be in writing and shall be hand delivered
or mailed postage prepaid by registered or certified mail or transmitted by facsimile transmission (with immediate telephonic confirmation
thereafter) or transmitted by email:

 

		(a)	If to the Holder:

 

B. Riley Principal Investments, LLC

11100 Santa Monica Blvd., Suite 800

Los Angeles, CA 90025

Attention: Daniel R. Palmadesso

Telephone: (646) 885-5548

E-mail: dpalmadesso@brileyfin.com

 

with a copy to (which shall
not constitute notice):

 

Morgan, Lewis & Bockius LLP

1400 Page Mill Road

Palo Alto, CA 94304-1124

Attention: Albert Lung and David Chang

Facsimile No.: (650) 843-4001

Telephone No.: (650) 843-7263

Email: albert.lung@morganlewis.com and david.chang@morganlewis.com

 

		(b)	If to the Company:

 

Cadiz Inc.

550 South Hope Street, Suite 2850

Los Angeles, California 90071

Attention: Chief Financial Officer

Facsimile No.: 213-271-1614

Email: sspeer@cadizinc.com

 

with a copy to (which shall
not constitute notice):

 

Greenberg Traurig, LLP

1840 Century Park East, Suite 1900

Los Angeles, CA 90067

Attention: Homin Lee

Telephone: (310) 586-7752

E-mail: leeho@gtlaw.com

 

or at such other address as the parties
each may specify by written notice to the others, and each such notice, request, consent and other communication shall for all purposes
of the Warrant be treated as being effective or having been given when delivered if delivered personally, upon receipt of facsimile confirmation
if transmitted by facsimile, upon transmission of email if transmitted by email, or, if sent by mail, at the earlier of its receipt or
72 hours after the same has been deposited in a regularly maintained receptacle for the deposit of United States mail, addressed and postage
prepaid as aforesaid.

 

    23

     

    

 

11.3 Indemnification.
If the Company fails to make, when due, any payments provided for in this Warrant, the Company shall pay to the Holder (a) interest at
the Applicable Rate on any amounts due and owing to such Holder and (b) such further amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys’ fees and expenses incurred by such Holder in collecting any amounts
due hereunder. The Company shall indemnify, defend and hold harmless the Holder and the Holders of any Warrant Stock issued upon the exercise
of this Warrant from and against any and all liability, loss, cost, damage, reasonable attorneys’ and accountants’ fees and
expenses, court costs and all other out-of-pocket expenses incurred in connection with or arising from any default hereunder by the Company
or the enforcement of its rights hereunder as against the Company. This indemnification provision shall be in addition to the rights of
such Holder or Holders to bring an action against the Company for breach of contract based on such default hereunder.

 

11.4 Limitation
of Liability. No provision hereof, in the absence of affirmative action by the Holder to purchase shares of Warrant Stock, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of such Holder to pay the Exercise Price
for any Warrant Stock other than pursuant to an exercise of this Warrant or any liability as a stockholder of the Company, whether such
liability is asserted by the Company or by creditors of the Company. The Holder shall not, by virtue hereof, be entitled to any rights
of a stockholder of the Company and nothing contained in this Warrant shall be construed as conferring upon the Holder the right to vote
or to consent or to receive notice as a stockholder in respect of meetings of stockholders for the election of directors of the Company
or any other matters or any rights whatsoever as a stockholder of the Company.

 

11.5 Remedies.
The Holder of the Warrant and/or Warrant Stock, in addition to being entitled to exercise its rights granted by law, including recovery
of damages, shall be entitled to specific performance of its rights provided under this Warrant. The Company agrees that monetary damages
would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees,
in an action for specific performance, to waive the defense that a remedy at law would be adequate.

 

11.6 Successors
and Assigns. This Warrant and the rights evidenced hereby shall inure to the benefit of and be binding upon the successors of the
Company and the permitted successors and assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of all
Holders from time to time of this Warrant and to the extent applicable, all Holders of shares of Warrant Stock issued upon the exercise
hereof (including transferees), and shall be enforceable by any such Holder.

 

11.7 Amendment.
The prior written consent of the Company and the Required Holders shall be required for any change, waiver or amendment to this Warrant.
Any change, waiver or amendment so approved shall be binding upon all existing and future holders of this Warrant and any other Warrants;
provided, however, that no such change, waiver or amendment, as applied to any of the Warrants held by any particular holder
of Warrants, shall, without the written consent of that particular holder, (i) disproportionately and materially adversely affect any
rights under such particular holder’s Warrant (other than as reflected by the different number of shares of Warrant Stock issuable
to such holder); or (ii) modify any of the provisions of, or impair the right of any holder of Warrants under, this Section 11.7. This
Warrant cannot be changed, modified, discharged or terminated by oral agreement.

 

    24

     

    

 

11.8 Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Warrant.

 

11.9 Headings.
The headings and other captions in this Warrant are for the convenience and reference only and shall not be used in interpreting, construing
or enforcing any provision of this Warrant.

 

11.10 Governing
Law. IN ALL RESPECTS, INCLUDING ALL MATTERS OF CONSTRUCTION, VALIDITY AND PERFORMANCE, THIS WARRANT SHALL BE GOVERNED BY, AND CONSTRUED
AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES AND ANY APPLICABLE LAWS
OF THE UNITED STATES OF AMERICA.

 

11.11 Jurisdiction.
Each of the Company and the Holder hereby irrevocably and unconditionally submits for itself and its property in any legal action or proceeding
relating to this Warrant, or for recognition and enforcement of any judgment in respect thereof, to the exclusive general jurisdiction
of the courts of the Supreme Court of the State of New York sitting in New York County, the courts of the United States for the Southern
District of New York, and appellate courts from any thereof, consents that any such action or proceeding may be brought in such courts
and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such
action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same, agrees that service of process in
any such action or proceeding may be effected by delivery of notice pursuant to Section 11.2 hereof and agrees that nothing herein shall
affect the right to effect service of process in any other manner permitted by law.

 

11.12 Waiver
of Jury Trial. EACH OF THE COMPANY AND THE HOLDER WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION
(A) ARISING UNDER THIS WARRANT OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THIS WARRANT OR THE TRANSACTIONS RELATED HERETO,
IN EACH CASE WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE. EACH OF THE COMPANY AND THE HOLDER AGREES AND CONSENTS THAT ANY SUCH CLAIM,
DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AGREEMENT MAY FILE AN ORIGINAL
COUNTERPART OR A COPY OF THIS CLAUSE WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE COMPANY AND THE HOLDER TO THE WAIVER OF
THEIR RIGHT TO TRIAL BY JURY. EACH OF THE COMPANY AND THE HOLDER ACKNOWLEDGES THAT IT HAS HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL
REGARDING THIS SECTION 11.12, THAT IT FULLY UNDERSTANDS ITS TERMS, CONTENT AND EFFECT, AND THAT IT VOLUNTARILY AND KNOWINGLY AGREES TO
THE TERMS OF THIS SECTION 11.12.

 

    25

     

    

 

11.13 Entire
Agreement. This Warrant contains the entire agreement with respect to the subject matter hereof and supersedes and replaces all other
prior agreements, written or oral, with respect to the subject matter hereof.

 

11.14 Originals.
A signed copy of this Warrant delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same
legal effect as delivery of an original copy of this Warrant.

 

[Signature Page Follows]

 

    26

     

    

 

IN WITNESS WHEREOF, the Company has caused this
Warrant to be duly executed as of the Original Issue Date.

 

	 	CADIZ INC.

 

	 	By:	/s/ Stanley Speer
	 	 	Name:	Stanley Speer
	 	 	Title:	Chief Financial Officer

 

[Signature page]

 

     

    

    

 

ANNEX A TO THE WARRANT

 

EXERCISE NOTICE

 

[To be executed only upon exercise of Warrant]

 

The undersigned registered owner of this Warrant
irrevocably exercises this Warrant for the purchase of ______ shares of Common Stock of Cadiz Inc. and herewith makes payment therefor
in __________, all at the price and on the terms and conditions specified in this Warrant and requests that the shares of Common Stock
hereby purchased (and any securities or other property issuable upon such exercise) be issued in the name of, and delivered to, as applicable,
_________________, whose address is __________________________________ ____________________________________________________________________,
and, if such shares of Common Stock shall not include all of the shares of Common Stock issuable as provided in this Warrant, that a new
Warrant of like tenor and date for the balance of the shares of Common Stock issuable hereunder be delivered to the undersigned.

 

TO DELETE THE FOLLOWING BRACKETED LANGUAGE IF
INAPPLICABLE AT EXERCISE DATE:[The undersigned hereby notifies Cadiz Inc. that a Holder Group would beneficially own a number of shares
of Common Stock in excess of the Beneficial Ownership Limitation set forth in this Warrant upon giving effect to this Exercise Notice.
Pursuant to such limitation, Cadiz Inc. shall give effect to this Exercise Notice in accordance with such limitation as of [INSERT DATE],
the date hereof].

 

	 	 
	 	(Name of Registered Owner)
	 	 
	 	 
	 	(Signature of Registered Owner)
	 	 
	 	 
	 	(Street Address)
	 	 
	 	 
	 	(City)      (State)      (Zip Code)

 

	NOTICE:	The signature on this Exercise Notice must correspond with the name as written upon the face of the within Warrant in every particular, without alteration or enlargement or any change whatsoever.

 

     

    

    

 

ANNEX B TO THE WARRANT

 

ASSIGNMENT FORM

 

FOR VALUE RECEIVED the undersigned registered owner
of this Warrant hereby assigns unto the assignee named below all of the rights of the undersigned under this Warrant, with respect to
the number of shares of Common Stock set forth below:

 

	Name and Address of Assignee	 	No. of Shares of Common Stock
	 	 	 
	 	 	 
	 	 	 

 

and does hereby irrevocably constitute and appoint ________ _____________
attorney-in-fact to register such transfer onto the books of Cadiz Inc. maintained for the purpose, with full power of substitution in
the premises.

 

	Dated:	Print Name:
	 	 
	Signature:	Witness
	 	 
	 	 
	NOTICE:	The signature on this assignment must correspond with the name as written upon the face of the within Warrant in every particular, without alteration or enlargement or any change whatsoever.Document

Exhibit 4.1
Execution Version

			
	

GXO LOGISTICS, INC.
DEBT SECURITIES
INDENTURE
Dated as of July 2, 2021
WELLS FARGO BANK, NATIONAL ASSOCIATION,
as Trustee
			
	

CROSS-REFERENCE TABLE
This Cross-Reference Table is not a part of the Indenture
						
	TIA Section	Indenture Section
	310(a)(1)	7.10

	(a)(2)	7.10

	(a)(3)	N.A.
	(a)(4)	N.A.
	(b)	7.08; 7.10; 11.02

	311(a)	7.11

	(b)	7.11

	312(a)	2.05

	(b)	11.03

	(c)	11.03

	313(a)	7.06

	(b)(1)	N.A.
	(b)(2)	7.06

	(c)	11.02

	(d)	7.06

	314(a)	4.03; 11.02

	(b)	N.A.
	(c)(1)	11.04

	(c)(2)	11.04

	(c)(3)	N.A.
	(d)	N.A.
	(e)	11.05

	315(a)	7.01(b)

	(b)	7.05; 11.02

	(c)	7.01(a)
	(d)	7.01(c)

	(e)	6.11

	316(a)(last sentence)	11.06

	(a)(1)(A)	6.05

	(a)(1)(B)	6.04

	(a)(2)	N.A.
	(b)	6.07

	(c)	9.04

	317(a)(1)	6.08

	(a)(2)	6.09

	(b)	2.04

	318(a)	11.01

	(c)	N.A.

N.A. means Not Applicable.
i

			
	TABLE OF CONTENTS

	

												
				PAGE

				
	This Table of Contents is not a part of the Indenture

				
	ARTICLE 1
DEFINITIONS AND INCORPORATION BY REFERENCE

				
	Section 1.01.		Definitions	1
	Section 1.02.		Other Definitions	6
	Section 1.03.		Incorporation by Reference of Trust Indenture Act	6
	Section 1.04.		Rules of Construction	6
				
	ARTICLE 2
THE SECURITIES

				
	Section 2.01.		Form and Dating	7
	Section 2.02.		Execution and Authentication	9
	Section 2.03.		Registrar and Paying Agent	10
	Section 2.04.		Paying Agent to Hold Money in Trust	10
	Section 2.05.		Securityholder Lists	11
	Section 2.06.		Transfer and Exchange	11
	Section 2.07.		Replacement Securities	12
	Section 2.08.		Outstanding Securities	12
	Section 2.09.		Temporary Securities	12
	Section 2.10.		Cancellation	12
	Section 2.11.		Defaulted Interest	12
	Section 2.12.		Treasury Securities	13
	Section 2.13.		CUSIP/ISIN Numbers	13
	Section 2.14.		Deposit of Moneys	13
	Section 2.15.		Book-Entry Provisions for Global Security	13
	Section 2.16.		No Duty to Monitor	15
				
	ARTICLE 3
REDEMPTION

				
	Section 3.01.		Notices to Trustee	15
	Section 3.02.		Selection of Securities to be Redeemed	16
	Section 3.03.		Notice of Redemption	16
	Section 3.04.		Effect of Notice of Redemption	17
	Section 3.05.		Deposit of Redemption Price	18
	Section 3.06.		Securities Redeemed in Part	18

ii

												
				
	ARTICLE 4
COVENANTS

				
	Section 4.01.		Payment of Securities	18
	Section 4.02.		Maintenance of Office or Agency	18
	Section 4.03.		Compliance Certificate	19
	Section 4.04.		Waiver of Stay, Extension or Usury Laws	19
	Section 4.05.		Commission Reports	19
	Section 4.06.		Limitation on Liens	20
				
	ARTICLE 5
SUCCESSOR PERSON

				
	Section 5.01.		When Company May Merge, etc.	22
				
	ARTICLE 6
DEFAULTS AND REMEDIES

				
	Section 6.01.		Events of Default	22
	Section 6.02.		Acceleration	23
	Section 6.03.		Other Remedies	24
	Section 6.04.		Waiver of Existing Defaults	24
	Section 6.05.		Control by Majority	25
	Section 6.06.		Limitation on Suits	25
	Section 6.07.		Rights of Holders to Receive Payment	25
	Section 6.08.		Collection Suit by Trustee	25
	Section 6.09.		Trustee May File Proofs of Claim	26
	Section 6.10.		Priorities	26
	Section 6.11.		Undertaking for Costs	26
				
	ARTICLE 7
TRUSTEE

				
	Section 7.01.		Duties of Trustee	26
	Section 7.02.		Rights of Trustee	28
	Section 7.03.		Individual Rights of Trustee	29
	Section 7.04.		Trustee’s Disclaimer	30
	Section 7.05.		Notice of Defaults	30
	Section 7.06.		Reports by Trustee to Holders	30
	Section 7.07.		Compensation and Indemnity	30
	Section 7.08.		Replacement of Trustee	31
	Section 7.09.		Successor Trustee by Merger, etc.	32
	Section 7.10.		Eligibility; Disqualification	32
	Section 7.11.		Preferential Collection of Claims Against Company	32

iii

												
				
	ARTICLE 8
DISCHARGE OF INDENTURE

				
	Section 8.01.		Defeasance upon Deposit of Moneys or Government Obligations; Satisfaction and Discharge	32
	Section 8.02.		Survival of the Company’s Obligations	36
	Section 8.03.		Application of Trust Money	36
	Section 8.04.		Repayment to the Company	36
	Section 8.05.		Reinstatement	36
				
	ARTICLE 9
AMENDMENTS, SUPPLEMENTS AND WAIVERS

				
	Section 9.01.		Without Consent of Holders	37
	Section 9.02.		With Consent of Holders	38
	Section 9.03.		Compliance with Trust Indenture Act	39
	Section 9.04.		Revocation and Effect of Consents	39
	Section 9.05.		Notation on or Exchange of Securities	39
	Section 9.06.		Trustee to Sign Amendments, etc.	40
				
	ARTICLE 10
SECURITIES IN FOREIGN CURRENCIES

				
	Section 10.01.		Applicability of Article	40
				
	ARTICLE 11
MISCELLANEOUS

				
	Section 11.01.		Trust Indenture Act Controls	40
	Section 11.02.		Notices	40
	Section 11.03.		Communications by Holders with Other Holders	42
	Section 11.04.		Certificate and Opinion as to Conditions Precedent	42
	Section 11.05.		Statements Required in Certificate or Opinion	42
	Section 11.06.		Rules by Trustee and Agents	43
	Section 11.07.		Legal Holidays	43
	Section 11.08.		Governing Law	43
	Section 11.09.		No Adverse Interpretation of Other Agreements	43
	Section 11.10.		No Recourse Against Others	43
	Section 11.11.		Successors and Assigns	43
	Section 11.12.		Duplicate Originals	43
	Section 11.13.		Severability	44
	Section 11.14.		PATRIOT ACT	44
	Section 11.15.		Waiver of Jury Trial	44
	Section 11.16.		Jurisdiction	44

EXHIBIT A – Form of Security
iv

INDENTURE dated as of July 2, 2021 (the “Base Indenture”), by and between GXO LOGISTICS, INC., a Delaware corporation (the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee (the “Trustee”).
Each party agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders of the Company’s debt securities issued under this Base Indenture:
ARTICLE 1
DEFINITIONS AND INCORPORATION BY REFERENCE
Section 1.01.    Definitions.
“Affiliate” means, when used with reference to a specified Person, any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Person specified.
“Agent” means any Registrar, Paying Agent or co-Registrar or agent for service of notices and demands.
“Authorizing Resolution” means a resolution adopted by the Board of Directors or by an Officer or committee of Officers pursuant to delegation by the Board of Directors authorizing a Series of Securities.
“Bankruptcy Law” means Title 11 of the United States Code, as amended, or any similar federal or state law for the relief of debtors.
“Board of Directors” means the Board of Directors of the Company or any duly authorized committee thereof.
“Business Day” means any calendar day that is not a Saturday or a Sunday or a day on which banking institutions in the City of New York (or any other place of payment with respect to the applicable Security) are authorized or required by law, regulation or executive order to close.
“capital stock” means, with respect to any Person, any and all shares, interests, participations or other equivalents (however designated) of or in such Person’s capital stock or other equity interests.
“Commission” means the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act or, if at any time after the execution of this Base Indenture such Commission is not existing and performing the duties now assigned to it under the TIA, then the body performing such duties at such time.
“Company” means the party named as such in this Indenture until a successor replaces it pursuant to the Indenture and thereafter means the successor.

“Consolidated Total Assets” means, as of the time of determination, total assets as reflected on the Company’s most recent consolidated balance sheet prepared as of the end of a fiscal quarter in accordance with GAAP which the Company shall have most recently filed with the Commission (or, if the Company is not required to so file, as reflected on its most recent consolidated balance sheet prepared in accordance with GAAP) prior to the time at which Consolidated Total Assets is being determined. The calculation of Consolidated Total Assets shall give pro forma effect to any acquisition by or disposition of assets of the Company or any of its Subsidiaries involving the payment or receipt by the Company or any of its Subsidiaries, as applicable, of consideration (whether in the form of cash or non-cash consideration) in excess of $500,000,000 that has occurred since the end of such fiscal quarter, as if such acquisition or disposition had occurred on the last day of such fiscal quarter.
“Continuing Entity” has the meaning set forth in Section 5.01(a)(i).
“control” means, when used with respect to any Person, the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.
“Default” means any event, act or condition that is, or after notice or the passage of time or both would be, an Event of Default.
“Definitive Security” means a certificated Security registered in the name of the Securityholder thereof.
“Depositary” means, with respect to Securities of any Series which the Company shall determine will be issued in whole or in part as a Global Security, DTC, another clearing agency, or any successor registered as a clearing agency under the Exchange Act, and any other applicable U.S. or foreign statute or regulation, which, in each case, shall be designated by the Company pursuant to Section 2.01.
“Dollars” or “$” means United States Dollars.
“Domestic Subsidiary” means any Subsidiary of the Company of which, at the time of determination, all of the outstanding capital stock (other than directors’ qualifying shares) is owned by the Company directly and/or indirectly and which, at the time of determination, is primarily engaged in contract logistics, other than a Subsidiary that (a) neither transacts any substantial portion of its business nor regularly maintains any substantial portion of its fixed assets within the United States, (b) all or substantially all of whose assets consist of the capital stock of one or more Subsidiaries which are not Domestic Subsidiaries, (c) a majority of whose Voting Stock is owned directly or indirectly by one or more Subsidiaries of the Company which are not Domestic Subsidiaries or (d) does not own a Principal Property.
“DTC” means The Depository Trust Company.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
2

“Foreign Currency” means any currency, currency unit or composite currency, including, without limitation, the euro, issued by the government of one or more countries other than the United States of America or by any recognized confederation or association of such governments.
“GAAP” means generally accepted accounting principles in the United States of America in effect from time to time.
“Global Security” means, with respect to any Series of Securities, a Security executed by the Company and delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction, all in accordance with the Indenture, which shall be registered in the name of the Depositary or its nominee.
“Government Obligations” means securities which are (i) direct obligations of the United States or the other government or governments in the confederation which issued the Foreign Currency in which the principal of or any interest on the Security of the applicable Series shall be payable, in each case for the payment of which its full faith and credit is pledged or (ii) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States or such other government or governments, in each case the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States or such other government or governments, which, in either case are not callable or redeemable at the option of the issuer or issuers thereof, and shall also include a depositary receipt issued by a bank or trust company as custodian with respect to any such Government Obligations or a specific payment of interest on or principal of any such Government Obligation held by such custodian for the account of the holder of a depositary receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the Government Obligation or the specific payment of interest on or principal of the Government Obligation evidenced by such depositary receipt.
“Holder” or “Securityholder” means the Person in whose name a Security is registered on the Registrar’s books.
“Indebtedness” means, with respect to any Person, debt (other than Non-recourse Obligations) of such Person for borrowed money.
“Indenture” means this Base Indenture as amended or supplemented from time to time, including pursuant to any Authorizing Resolution or supplemental indenture pertaining to any Series, and including, for all purposes of this instrument and any such Authorizing Resolution or supplemental indenture, the provisions of the TIA that are deemed to be a part of and govern this Base Indenture and any such Authorizing Resolution or supplemental indenture, respectively.
“Issue Date” means, with respect to any Series of Securities, the date on which the Securities of such Series are originally issued under this Indenture.
3

“Lien” means any lien, security interest, pledge, mortgage, conditional sale or other title retention agreement or other similar encumbrance.
“Non-recourse Obligation” means Indebtedness (A) substantially related to (1) the acquisition of assets not previously owned by the Company or any of its Subsidiaries or (2) the financing of a project involving the development or expansion of properties of the Company or any of its Subsidiaries, or (B) renewing, refinancing, replacing or extending any of the types of Indebtedness referred to in the preceding clause (A), in each case, as to which the obligee with respect to such Indebtedness has no recourse to the Company or its assets other than the assets which were acquired with the proceeds of such transaction or the project financed with the proceeds of such transaction (and the proceeds thereof), provided that Indebtedness will not fail to qualify as Non-recourse Obligations solely because the Company has indemnified any such obligee against damages resulting from or is otherwise obligated to such obligee in respect of exceptions to non-recourse liability in general usage (as determined in good faith by the Board of Directors or any Senior Officer of the Company) in the relevant industry at the time such Indebtedness is incurred (such as fraud, waste, misapplication of funds, failure to maintain insurance coverage, and environmental liability).
“Notice of Default” has the meaning specified in Section 6.01(c). 
“NYUCC” means the New York Uniform Commercial Code, as in effect from time to time.
“Officer” means the Chairman of the Board, the Chief Executive Officer, the Chief Financial Officer, the Chief Accounting Officer, the President, any Vice President, the Treasurer, the Assistant Treasurer, the Controller or the Secretary of the Company.
“Officer’s Certificate” means a certificate signed by an Officer of the Company. 
“Opinion of Counsel” means a written opinion of counsel, which may be an employee of or counsel for the Company, any Subsidiary of the Company or any Person of which the Company is a Subsidiary, and who shall be reasonably acceptable to the Trustee.
“Person” means any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust, unincorporated organization or government or political subdivision thereof.
“principal” of a debt security means the principal of the security plus, when appropriate, the premium, if any, on the security.
“Principal Property” means the land, improvements, buildings and fixtures constituting any research and development facility or service and support facility that is real property located within the territorial limits of the United States (excluding its territories and possessions and Puerto Rico) owned or leased by the Company or any of its Domestic Subsidiaries and having a net book value which, on the date of determination as to whether a Property is a Principal Property is being made, exceeds 2% 
4

of Consolidated Total Assets, other than (a) any such facility as any of the Board of Directors determines in good faith is not of material importance to the total business conducted, or assets owned, by the Company and its Subsidiaries, taken as a whole, and (b) the Company’s principal corporate offices.
“Property” means any property or asset, whether real, personal or mixed, or tangible or intangible, including shares of capital stock.
“Securities” means any securities that are issued under this Base Indenture. 
“Securities Act” means the U.S. Securities Act of 1933, as amended.
“Senior Officer” of any specified Person means the Chief Executive Officer, any President, any Vice President, the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the Secretary or any Assistant Secretary of such Person.
“Series” means a series of Securities established under this Base Indenture.
“Subsidiary” means any corporation or other entity of which at least a majority of the outstanding capital stock or other equity interests having by the terms thereof ordinary voting power to elect a majority of the directors, managers or trustees of such corporation or other entity, irrespective of whether or not at the time capital stock or other equity securities of any other class or classes of such corporation or other entity shall have or might have voting power by reason of the happening of any contingency, is at the time, directly or indirectly, owned or controlled by the Company or by one or more of its Subsidiaries, or by the Company and one or more of its Subsidiaries.
“TIA” means the Trust Indenture Act of 1939, as amended.
“Trust Officer” means, when used with respect to the Trustee, any officer within the corporate trust department of the Trustee, including any vice president, assistant vice president, assistant secretary, senior associate, associate, trust officer or any other officer of the Trustee who customarily performs functions similar to those performed by the Persons who at the time shall be such officers, respectively, or to whom any corporate trust matter is referred because of such person’s knowledge of and familiarity with the particular subject and who, in each case, shall have direct responsibility for the administration of this Indenture.
“Trustee” means the party named as such in this Base Indenture until a successor replaces it pursuant to this Base Indenture and thereafter means the successor serving hereunder; provided, however, that if at any time there is more than one such Person, “Trustee” as used with respect to the Securities of any Series shall mean only the Trustee with respect to Securities of that Series.
“United States” means the United States of America.
“Voting Stock” of any specified Person as of any date means the capital stock of such Person that is at the time entitled to vote generally in the election of the board of 
5

directors or managers of such Person (or if such Person is a partnership, the board of directors or other governing body of the general partner of such Person).
Section 1.02.    Other Definitions.  
									
	Term		Defined in Section

	Agent Members		2.15(a)

	Applicable Deficit		8.01(e)
	Base Indenture		Preamble
	Covenant Defeasance		8.01(c)

	Event of Default		6.01

	Legal Defeasance		8.01(b)

	Legal Holiday		11.07

	Paying Agent		2.03

	Registrar		2.03

	Security Register		2.03
	Signature Law		11.12

Section 1.03.    Incorporation by Reference of Trust Indenture Act.  Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture.  The following TIA terms used in this Indenture have the following meanings:
“indenture securities” means the Securities of a particular Series.
“obligor” on the indenture securities means the Company or any other obligor on the Securities of a Series.
All other TIA terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by Commission rule have the meanings so assigned to them.
Section 1.04.    Rules of Construction.  Unless the context otherwise requires:
(a)    a term has the meaning assigned to it herein;
(b)    an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP and all accounting determinations shall be made in accordance with GAAP;
(c)    “or” is not exclusive and “including” means “including without limitation”;
(d)    words in the singular include the plural, and in the plural include the singular;
(e)    “herein,” “hereof” and “hereunder,” and other words of similar import, refer to this Indenture as a whole (including any Authorizing Resolution or supplemental 
6

indenture relating to the relevant Series) and not to any particular Article, Section or other subdivision;
(f)    all exhibits are incorporated by reference herein and expressly made a part of this Indenture; and
(g)    any transaction or event shall be considered “permitted by” or made “in accordance with” or “in compliance with” this Indenture or any particular provision hereof if such transaction or event is not expressly prohibited by this Indenture or such provision, as the case may be.
ARTICLE 2
THE SECURITIES
Section 2.01.    Form and Dating.  The aggregate principal amount of Securities that may be issued under this Base Indenture is unlimited.  The Securities may be issued from time to time in one or more Series.  Each Series shall be created by an Authorizing Resolution, an Officer’s Certificate or a supplemental indenture that establishes the terms of the Series, which may include the following:
(a)    the title of the Series;
(b)    the aggregate principal amount (or any limit on the aggregate principal amount) of the Series and, if any Securities of a Series are to be issued at a discount from their face amount, or with a premium, the method of computing the accretion of such discount or computing such premium;
(c)    the interest rate or method of calculation of the interest rate;
(d)    the date from which interest will accrue;
(e)    the record dates for interest payable on Securities of the Series;
(f)    the dates when, places where and manner in which principal and interest are payable;
(g)    if there is more than one Trustee or a Trustee other than Wells Fargo Bank, National Association, the identity of the Trustee and, if not the Trustee, the identity of each Registrar, Paying Agent or authenticating agent with respect to such Securities;
(h)    the terms of any mandatory (including any sinking fund requirements) or optional redemption by the Company;
(i)    the terms of any redemption at the option of Holders;
(j)    the permissible denominations in which Securities of such Series are issuable, if different from $2,000 and multiples of $1,000 in excess thereof;
7

(k)    whether Securities of such Series will be issued in registered or bearer form and the terms of any such forms of Securities;
(l)    whether the Securities of the Series shall be issued in whole or in part in the form of a Global Security or Securities; the terms and conditions, if different from those contained in this Base Indenture, upon which such Global Security or Securities may be exchanged in whole or in part for Definitive Securities; the Depositary for such Global Security or Securities; and the form of any legend or legends, if any, to be borne by any such Global Security or Securities in addition to or in lieu of the legends referred to in Section 2.15;
(m)    the currency or currencies (including any composite currency) in which principal or interest or both may be paid and the agency or organization, if any, responsible for overseeing any composite currency;
(n)    if payments of principal or interest may be made in a currency other than that in which Securities of such Series are denominated, the manner for determining such payments, including the time and manner of determining the exchange rate between the currency in which such Securities are denominated and the currency in which such Securities or any of them may be paid, and any deletions from or modifications of or additions to the terms of this Base Indenture to provide for or to facilitate the issuance of Securities denominated or payable, at the election of the Company or a Holder thereof or otherwise, in a Foreign Currency;
(o)    whether the amount of payments of principal of or any interest on such Securities may be determined with reference to an index, formula, financial or economic measure or other method or methods (which index, formula, measure or method or methods may be based, without limitation, on one or more currencies, commodities, equity indices or other indices) and if so, the terms and conditions upon which and the manner in which such amounts shall be determined and paid or be payable;
(p)    provisions for electronic issuance of Securities or issuance of Securities of such Series in uncertificated form;
(q)    any Events of Default, covenants, defined terms and/or other terms in addition to or in lieu of those set forth in this Base Indenture;
(r)    whether and upon what terms Securities of such Series may be defeased or discharged if different from the provisions set forth in this Base Indenture;
(s)    the form of the Securities of such Series, which, unless the Authorizing Resolution, Officer’s Certificate or supplemental indenture otherwise provides, shall be in the form of Exhibit A;
(t)    any terms that may be required by or advisable under applicable law;
8

(u)    the percentage of the principal amount of the Securities of such Series which is payable if the maturity of the Securities of such Series is accelerated in the case of Securities issued at a discount from their face amount;
(v)    whether Securities of such Series will or will not have the benefit of guarantees and, if applicable, the terms and conditions upon which such guarantees may be subordinated to other indebtedness of the respective guarantors;
(w)    whether the Securities of such Series are unsubordinated or subordinated debt securities, and if subordinated debt securities, the terms of such subordination;
(x)    whether the Securities of the Series will be convertible into or exchangeable for other Securities, capital stock or other securities of any kind of the Company or another Person or Persons, and, if so, the terms and conditions upon which such Securities will be so convertible or exchangeable, including the initial conversion or exchange price or rate or the method of calculation, how and when the conversion price or exchange ratio may be adjusted, whether conversion or exchange is mandatory, at the option of the holder or at the Company’s option, the conversion or exchange period, and any other provision in relation thereto; and
(y)    any other terms in addition to or different from those contained in this Base Indenture applicable to such Series.
All Securities of one Series need not be issued at the same time and, unless otherwise provided, a Series may be reopened for issuances of additional Securities of such Series pursuant to an Authorizing Resolution, an Officer’s Certificate or in any indenture supplemental hereto.
The creation and issuance of a Series and the authentication and delivery thereof are not subject to any conditions precedent.
Section 2.02.    Execution and Authentication.  One Officer shall sign the Securities for the Company by manual or facsimile signature.
If an Officer whose signature is on a Security no longer holds that office at the time the Trustee authenticates the Security, the Security shall nevertheless be valid.
A Security shall not be valid until the Trustee manually signs the certificate of authentication on the Security.  The signature shall be conclusive evidence that the Security has been authenticated under this Base Indenture.
At any time and from time to time after the execution and delivery of this Base Indenture, the Company may deliver Securities of any series executed by the Company to the Trustee for authentication.  Each Security shall be dated the date of its authentication.  The Trustee shall authenticate Securities for original issue upon receipt of, and shall be fully protected in relying upon:
9

(a)    an order to the Trustee signed by an Officer of the Company directing the Trustee to authenticate the Securities;
(b)    an Officer’s Certificate of the Company delivered in accordance with Section 11.04; and
(c)    other than in connection with the authentication of the Securities issued on the date hereof pursuant to this Indenture, an Opinion of Counsel delivered in accordance with Section 11.04.
(d)    The Trustee shall have the right to decline to authenticate and deliver any Securities under this Section if the Trustee, being advised by counsel, determines that such action may not lawfully be taken or if the Trustee in good faith shall determine that such action would expose the Trustee to personal liability to existing Holders.
Section 2.03.    Registrar and Paying Agent.  The Company shall maintain an office or agency where Securities may be presented for registration of transfer or where Securities of a Series that are convertible or exchangeable may be surrendered for conversion or exchange (“Registrar”), an office or agency where Securities may be presented for payment (“Paying Agent”) and an office or agency where notices and demands to or upon the Company in respect of the Securities and this Indenture may be served.  The Registrar shall keep a register of the Securities and of their transfer and exchange (the “Security Register”).  The Company may have one or more co-Registrars and one or more additional paying agents.  The term “Paying Agent” includes any additional paying agent.  The Company may at any time rescind the designation of any Registrar or Paying Agent or approve a change in the office through which the Registrar or Paying Agent acts.
The Company shall enter into an appropriate agency agreement with any Agent not a party to this Base Indenture.  The agreement shall implement the provisions of this Indenture that relate to such Agent.  The Company shall promptly notify the Trustee in writing of the name and address of any such Agent, and the Trustee shall have the right to inspect the Security Register at all reasonable times to obtain copies thereof, and the Trustee shall have the right to rely upon such register as to the names and addresses of the Holders and the principal amounts and certificate numbers thereof.  If the Company fails to maintain a Registrar or Paying Agent or fails to give the foregoing notice, the Trustee shall act as such.
The Company initially appoints the Trustee as Registrar and Paying Agent.
Section 2.04.    Paying Agent to Hold Money in Trust.  Each Paying Agent shall hold in trust for the benefit of Securityholders and the Trustee all money held by the Paying Agent for the payment of principal of or interest on the Securities, and shall notify the Trustee of any default by the Company in making any such payment.  If the Company or a Subsidiary acts as Paying Agent, it shall segregate the money and hold it as a separate trust fund.  The Company at any time may require a Paying Agent to pay all money held by it to the Trustee.  Upon doing so the Paying Agent shall have no further 
10

liability for the money.  Upon an Event of Default under Section 6.01(d) or Section 6.01(e), the Trustee shall automatically be the Paying Agent.
Section 2.05.    Securityholder Lists.  The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Securityholders.  If the Trustee is not the Registrar, the Company shall furnish to the Trustee at least five (5) Business Days before each semiannual interest payment date and at such other times as the Trustee may request in writing a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of Securityholders.
Section 2.06.    Transfer and Exchange.  Where a Security is presented to the Registrar or a co-Registrar with a request to register a transfer, the Registrar shall register the transfer as requested if the requirements of Section 8-401(a) of the NYUCC are met and the other provisions of this Section 2.06 and, to the extent applicable, Section 2.15, are satisfied.  Where Securities are presented to the Registrar or a co-Registrar with a request to exchange them for an equal principal amount of Securities of other denominations, the Registrar shall make the exchange as requested if the same requirements are met.  To permit transfers and exchanges, the Trustee shall authenticate Securities at the Registrar’s request.  The Registrar need not transfer or exchange any Security selected for redemption or transfer or exchange any Security for a period of 15 days before a selection of Securities to be redeemed or repurchased.  Any exchange or transfer shall be without charge, except that the Company may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto, except in the case of exchanges pursuant to Section 2.09, 3.06 or 9.05 not involving any transfer.  In connection with the foregoing, the Registrar may require a Holder to furnish appropriate endorsements and transfer documents.
Any Holder of a Global Security shall, by acceptance of such Global Security, agree that transfers of beneficial interests in such Global Security may be effected only through a book-entry system maintained by the Holder of such Global Security (or its agent), and that ownership of a beneficial interest in the Security shall be required to be reflected in a book entry.
Section 2.07.    Replacement Securities.  If the Holder of a Security claims that the Security has been lost, destroyed, mutilated or wrongfully taken, the Company shall issue and execute a replacement security and, upon written request of any Officer of the Company, the Trustee shall authenticate such replacement Security; provided, in the case of a lost, destroyed or wrongfully taken Security, that the requirements of Section 8-405 of the NYUCC are met.  If any such lost, destroyed, mutilated or wrongfully taken Security shall have matured or shall be about to mature, the Company may, instead of issuing a substitute Security therefor, pay such Security without requiring (except in the case of a mutilated Security) the surrender thereof.  An indemnity bond must be sufficient in the judgment of the Trustee to protect the Trustee and in the judgment of the Company to protect the Company, the Trustee and any Agent from any loss which any of them may suffer if a Security is replaced, including the acquisition of such Security by a bona fide 
11

purchaser.  The Company and the Trustee may charge for their expenses in replacing a Security.
Section 2.08.    Outstanding Securities.  Securities outstanding at any time are all Securities authenticated by the Trustee except for those cancelled by it and those described in this Section.  A Security does not cease to be outstanding because the Company or one of its Affiliates holds the Security.
If a Security is replaced pursuant to Section 2.07, it ceases to be outstanding unless the Trustee receives proof satisfactory to it that the replaced Security is held by a “protected purchaser” (as such term is defined in the NYUCC).
If the Paying Agent holds on a redemption date, purchase date or maturity date money sufficient to pay Securities payable on that date, then on and after that date such Securities cease to be outstanding and interest on them ceases to accrue.
Subject to the foregoing provisions of this Section, each Security delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of any other Security shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security.
Section 2.09.    Temporary Securities.  Until Definitive Securities are ready for delivery, the Company may execute and the Trustee shall (upon receipt of an order from the Company) authenticate temporary Securities.  Temporary Securities shall be substantially in the form of Definitive Securities but may have variations that the Company considers appropriate for temporary Securities.  Without unreasonable delay, the Company shall prepare and, upon surrender for cancellation of the temporary Security, the Company shall execute and the Trustee shall authenticate Definitive Securities in exchange for temporary Securities.  Until so exchanged, the temporary Securities shall in all respects be entitled to the same benefits under this Indenture as Definitive Securities authenticated and delivered hereunder.
Section 2.10.    Cancellation.  The Company at any time may deliver Securities to the Trustee for cancellation.  The Registrar and Paying Agent shall forward to the Trustee any Securities surrendered to them for registration of transfer, exchange, redemption, purchase or payment.  The Trustee and no one else shall cancel and dispose of such cancelled or tendered Securities, or retain in accordance with its standard retention policy, all Securities surrendered for registration of transfer, exchange, redemption, purchase, payment or cancellation.  Unless the Authorizing Resolution, Officer’s Certificate or supplemental indenture so provides, the Company may not issue new Securities to replace Securities that it has previously paid or delivered to the Trustee for cancellation.
Section 2.11.    Defaulted Interest.  If the Company defaults in a payment of interest on the Securities of any Series, it shall pay the defaulted interest plus any interest payable on the defaulted interest to the persons who are Securityholders of such Series on a subsequent special record date.  The Company shall fix such special record date and a 
12

payment date.  At least 15 days before such special record date, the Company shall send to each Securityholder of the relevant Series (with a copy to the Trustee) a notice that states the record date, the payment date and the amount of defaulted interest to be paid.  On or before the date such notice is sent, the Company shall deposit with the Paying Agent money sufficient to pay the amount of defaulted interest to be so paid.  The Company may pay defaulted interest in any other lawful manner if, after notice given by the Company to the Trustee of the proposed payment, such manner of payment shall be deemed practicable by the Trustee.
Section 2.12.    Treasury Securities.  In determining whether the Holders of the required principal amount of Securities of a Series have concurred in any direction, waiver, consent or notice, Securities owned by the Company or any of its Affiliates shall be considered as though they are not outstanding, except that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Securities which a Trust Officer of the Trustee actually knows are so owned shall be so considered.
Section 2.13.    CUSIP/ISIN Numbers.  The Company in issuing the Securities of any Series may use a “CUSIP” and/or “ISIN” or other similar number, and if so, the Trustee shall use the CUSIP and/or ISIN or other similar number in notices of redemption or exchange as a convenience to Holders of such Securities; provided that no representation is hereby deemed to be made by the Trustee as to the correctness or accuracy of any such CUSIP and/or ISIN or other similar number printed in the notice or on such Securities, and that reliance may be placed only on the other identification numbers printed on such Securities.  The Company shall promptly notify the Trustee of any change in any CUSIP and/or ISIN or other similar number.
Section 2.14.    Deposit of Moneys.  Prior to 11:00 a.m., New York City time, on each interest payment date and maturity date with respect to each Series of Securities, the Company shall have deposited with the Paying Agent in immediately available funds money in the applicable currency sufficient to make cash payments due on such interest payment date or maturity date, as the case may be, in a timely manner which permits the Paying Agent to remit payment to the Holders of such Series on such interest payment date or maturity date, as the case may be.
Section 2.15.    Book-Entry Provisions for Global Security.  (a)  Any Global Security of a Series initially shall (i) be registered in the name of the Depositary or the nominee of such Depositary, (ii) be delivered to the Trustee as custodian for such Depositary and (iii) bear any required legends.
Members of, or participants in, the Depositary (“Agent Members”) shall have no rights under this Indenture with respect to any Global Security held on their behalf by the Depositary, or the Trustee as its custodian, or under the Global Security, and the Depositary may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner of the Global Security for all purposes whatsoever.  Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any written certification, 
13

proxy or other authorization furnished by the Depositary or impair, as between the Depositary and its Agent Members, the operation of customary practices governing the exercise of the rights of a Holder of any Security.
(b)    Transfers of any Global Security shall be limited to transfers in whole, but not in part, to the Depositary, its successors or their respective nominees.  Global Securities of a Series will be exchangeable for Definitive Securities of such Series without interest coupons only in the following limited circumstances: (i) the Depositary (A) notifies the Company that it is unwilling or unable to continue as depositary for such Global Securities of such Series or (B) has ceased to be a clearing agency registered under the Exchange Act, and in either case, the Company fails to appoint a successor Depositary within 90 days; or (ii) the Company notifies the Trustee in writing that the Company has elected to cause the issuance of such Definitive Securities of such Series under the Indenture.  In all such cases, Definitive Securities delivered in exchange for any Global Securities or beneficial interests therein will be registered in the names, and issued in any approved denominations, requested by or on behalf of the Depositary (in accordance with its customary procedures).
(c)    In connection with any transfer or exchange of a portion of the beneficial interest in any Global Security to beneficial owners pursuant to paragraph (b), the Registrar shall (if one or more Definitive Securities are to be issued) reflect on its books and records the date and a decrease in the principal amount of the Global Security in an amount equal to the principal amount of the beneficial interest in the Global Security to be transferred, and the Company shall execute, and the Trustee shall authenticate and deliver, one or more Definitive Securities of like Series and amount.
(d)    In connection with the transfer of an entire Global Security to beneficial owners pursuant to paragraph (b), the Global Security shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall execute, and the Trustee shall authenticate and deliver, to each beneficial owner identified by the Depositary in exchange for its beneficial interest in the Global Security, an equal aggregate principal amount of Definitive Securities of the same Series in authorized denominations.
(e)    The Holder of any Global Security may grant proxies and otherwise authorize any person, including Agent Members and persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under this Indenture or the Securities of such Series.
(f)    Unless otherwise provided in the Authorizing Resolution or supplemental indenture for a particular Series of Securities, each Global Security of such Series shall bear legends in substantially the following forms:
“THIS GLOBAL SECURITY IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS SECURITY) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE HOLDERS OF BENEFICIAL INTERESTS HEREIN, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY 
14

CIRCUMSTANCES, EXCEPT THAT (I) THE TRUSTEE MAY MAKE ANY SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO THE INDENTURE, (II) THIS GLOBAL SECURITY MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.06 OF THE BASE INDENTURE, (III) THIS GLOBAL SECURITY MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO THE INDENTURE AND (IV) THIS GLOBAL SECURITY MAY BE TRANSFERRED AS A WHOLE, BUT NOT IN PART, TO THE DEPOSITARY, ITS SUCCESSORS OR THEIR RESPECTIVE NOMINEES.
UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.”
Section 2.16.    No Duty to Monitor.  The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Security (including any transfers between or among Agent Members or beneficial owners of interests in any Global Security) other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof.
Neither the Trustee nor any Agent shall have any responsibility for any actions taken or not taken by the Depositary.
ARTICLE 3
REDEMPTION
Section 3.01.    Notices to Trustee.  Securities of a Series that are redeemable prior to maturity shall be redeemable in accordance with their terms and, unless the Authorizing Resolution, Officer’s Certificate or supplemental indenture provides otherwise, in accordance with this Article 3.
15

If the Company wants to redeem Securities pursuant to any provisions of such Securities permitting the Company to redeem such Securities at its option, it shall notify the Trustee in writing of the redemption date and the principal amount of Securities to be redeemed.  Any such notice may be cancelled at any time prior to notice of such redemption being sent to Holders.  Any such cancelled notice shall be void and of no effect.
If the Company wants to credit any Securities previously redeemed, retired or acquired against any redemption pursuant to any provisions of such Securities requiring the Company to redeem such Securities, it shall notify the Trustee of the amount of the credit and it shall deliver any Securities not previously delivered to the Trustee for cancellation with such notice.
The Company shall give each notice provided for in this Section 3.01 at least two days before the notice of any such redemption is to be delivered to Holders (unless a shorter notice shall be satisfactory to the Trustee).
Section 3.02.    Selection of Securities to be Redeemed.  If fewer than all of the Securities of a Series are to be redeemed, the Trustee (or Depositary, as applicable) shall select the Securities to be redeemed pro rata, by lot or such other method the Trustee (or Depositary, as applicable) considers fair and appropriate and in a manner that complies with applicable requirements of the Depositary.  The Trustee (or Depositary, as applicable) shall make the selection from Securities outstanding not previously called for redemption and shall promptly notify the Company of the serial numbers or other identifying attributes of the Securities so selected.  The Trustee (or Depositary, as applicable) may select for redemption portions of the principal of Securities that have denominations larger than the minimum denomination for the Series.  Securities and portions of them it selects shall be in amounts equal to a permissible denomination for the Series.  Provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called for redemption.
Unless otherwise provided in the Authorizing Resolution, Officer’s Certificate or supplemental indenture relating to a Series, if any Security selected for partial redemption is converted into or exchanged for capital stock or other securities, cash or other property in part before termination of the conversion or exchange right with respect to the portion of the Security so selected, the converted portion of such Security shall be deemed (so far as may be) to be the portion selected for redemption.  Securities which have been converted or exchanged during a selection of Securities to be redeemed shall be treated by the Trustee as outstanding for the purpose of such selection.
Section 3.03.    Notice of Redemption.  At least 10 days but not more than 60 days before a redemption date, the Company shall send a notice of redemption by first-class mail, postage prepaid (or in the case of Global Securities, deliver electronically in accordance with the applicable procedures of the Depositary), to each Holder of Securities to be redeemed (with a copy to the Trustee).
The notice shall identify the Securities to be redeemed and shall state:
16

(a)    the redemption date and any conditions precedent to such redemption;
(b)    the redemption price or the formula pursuant to which such price will be calculated;
(c)    if any Security is being redeemed in part, the portion of the principal amount of such Security to be redeemed;
(d)    in the case of Securities of a Series that are convertible or exchangeable into shares of the Company’s capital stock or other securities, cash or other property, the conversion or exchange price or rate, the date or dates on which the right to convert or exchange the principal of the Securities of such Series to be redeemed will commence or terminate and the place or places where such Securities may be surrendered for conversion or exchange;
(e)    the name and address of the Paying Agent;
(f)    that Securities called for redemption must be surrendered to the Paying Agent to collect the redemption price;
(g)    that, unless the Company defaults in payment of the redemption price, interest on Securities called for redemption ceases to accrue on and after the redemption date;
(h)    that the Securities are being redeemed pursuant to the mandatory redemption or the optional redemption provisions, as applicable; and
(i)    the CUSIP number and that no representation is hereby deemed to be made be made by the Trustee as to the correctness or accuracy of any such CUSIP and/or ISIN or other similar number printed in the notice or on such Securities, and that reliance may be placed only on the other identification numbers printed on such Securities.
At the Company’s request, the Trustee shall give the notice of redemption in the Company’s name and at its expense; provided, however, that the Company shall deliver to the Trustee at least two days prior to the date on which notice of redemption is to be sent or such shorter period as may be satisfactory to the Trustee, such notice and an Officer’s Certificate requesting that the Trustee give such notice and setting forth the information to be stated in such notice as provided in the preceding paragraph.
Section 3.04.    Effect of Notice of Redemption.  Once notice of redemption is sent, Securities called for redemption become due and payable on the redemption date and at the redemption price as set forth in the notice of redemption, unless otherwise specified in such notice of redemption.  Upon surrender to the Paying Agent, such Securities shall be paid at the redemption price, plus accrued and unpaid interest to the redemption date.  
Any notice of redemption of any Series of Securities may, at the Company’s discretion, be subject to one or more conditions precedent with respect to completion of a corporate transaction (including, but not limited to, any merger, acquisition, disposition, 
17

asset sale or corporate restructuring or reorganization) or financing (including, but not limited to, any incurrence of indebtedness (or entering into a commitment with respect thereto), sale and leaseback transaction, issuance of securities, equity offering or contribution, liability management transaction or other capital raise) and may be given prior to the completion thereof. If a redemption is subject to satisfaction of one or more conditions precedent, the notice shall describe each condition, and the notice may be rescinded in the event that any or all of the conditions shall not have been satisfied on or prior to the redemption date; provided, however that in no event may such notice be rescinded later than 10:00 a.m. New York City time on the redemption date. Any notice of redemption may provide that payment of the redemption price and the Company’s obligations with respect to the redemption may be performed by another Person.
Section 3.05.    Deposit of Redemption Price.  On or before the redemption date, the Company shall deposit with the Paying Agent immediately available funds in the applicable currency sufficient to pay the redemption price of and accrued interest on all Securities to be redeemed on that date.  Unless the Company defaults in payment of the redemption price, on and after the redemption date interest will cease to accrue on the Securities, or portions thereof, called for redemption.
Section 3.06.    Securities Redeemed in Part.  Upon surrender of a Definitive Security that is redeemed in part, the Company shall execute and the Trustee shall authenticate for each Holder a new Definitive Security of the same Series equal in principal amount to the unredeemed portion of the Definitive Security surrendered.  If any Global Security is redeemed in part, the records of the Trustee shall reflect such decrease in the principal amount of such Global Security.
ARTICLE 4
COVENANTS
Section 4.01.    Payment of Securities.  The Company shall pay the principal of and interest on a Series on the dates, in the currency and in the manner provided in the Securities of the Series.  An installment of principal or interest shall be considered paid on the date it is due if the Paying Agent holds on that date money in the applicable currency designated for and sufficient to pay the installment.
The Company shall pay interest on overdue principal at the rate borne by the Series; it shall pay interest on overdue installments of interest at the same rate.
Section 4.02.    Maintenance of Office or Agency.  The Company shall maintain the office or agency required under Section 2.03.  The Company shall give prior written notice to the Trustee of the location, and any change in the location, of such office or agency.  If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the address of the Trustee, provided that the Trustee shall not be the agent for service of legal process on the Company.
18

Section 4.03.    Compliance Certificate.  The Company shall deliver to the Trustee within 120 days after the end of each fiscal year of the Company an Officer’s Certificate stating whether or not the signer knows of any continuing Default by the Company in performing any of its obligations under this Indenture.  If the signer does know of such a Default, the certificate shall describe the Default.
Section 4.04.    Waiver of Stay, Extension or Usury Laws.  The Company covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, plead or in any manner whatsoever claim or take the benefit or advantage of any stay or extension law or any usury law or other law that would prohibit or forgive the Company from paying all or any portion of the principal of or interest on the Securities of any Series as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Indenture; and (to the extent that it may lawfully do so) the Company expressly waives all benefit or advantage of any such law, and covenants that it will not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted.
Section 4.05.    Commission Reports.  
(a)    During any time period in which the TIA applies to the Indenture or Securities of any Series, the Company shall file with the Trustee and the Commission, such information, documents and other reports, and such summaries thereof, as may be required pursuant to the TIA at the times and in the manner provided pursuant to the TIA; provided that any such information, documents or reports required to be filed with the Commission pursuant to Section 13 or 15(d) of the Exchange Act shall be filed with the Trustee within 15 days after the same is so required to be filed with the Commission. The Company will be deemed to have complied with the obligations described in the immediately previous sentence to the extent that the information, documents and reports are filed with the Commission via EDGAR (or any successor electronic delivery procedure) and posted on the Company’s website or otherwise publicly available. For the avoidance of doubt, neither this Base Indenture nor the Securities will initially be qualified under the TIA as of the date hereof.
(b)    Delivery of the reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants under the Indenture as to which the Trustee is entitled to rely conclusively on an Officer’s Certificate. The Trustee shall have no liability or responsibility for the filing, timeliness or content of such reports.
(c)    During any time period in which the TIA does not apply to the Indenture or Securities of any Series, for so long as any such Securities remain outstanding, the Company will furnish to the Holders and to prospective investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act.
19

Section 4.06.    Limitation on Liens.  
(a)    If the Company or any of its Domestic Subsidiaries incurs, issues, assumes or guarantees any Indebtedness and that Indebtedness is secured by a Lien on any of the Principal Properties of the Company or any of its Domestic Subsidiaries, the Company will secure the Securities of each Series equally and ratably with, or prior to, such secured Indebtedness, so long as such secured Indebtedness shall be so secured.
(b)    The foregoing restriction shall not apply, with respect to any Series, to:
(i)    Liens on Property of a Person existing at the time such Person is merged into or consolidated with the Company or any of its Subsidiaries, at the time such Person becomes a Subsidiary of the Company, or at the time of a sale, lease or other disposition of all or substantially all of the Properties or assets of a Person to the Company or any of the Company’s Subsidiaries; provided that such Lien was not incurred in anticipation of the merger, consolidation, sale, lease, or other disposition;
(ii)    Liens on Property existing at the time of acquisition by the Company or any of its Subsidiaries of such Property (which may include Property previously leased by the Company or any of its Subsidiaries and leasehold interests on such Property, provided that the lease terminates prior to or upon the acquisition);
(iii)    Liens on Property to secure the payment of all or any part of the cost of acquisition, construction, development or improvement of such Property, or to secure Indebtedness incurred to provide funds for any such purpose, provided that the commitment of the creditor to extend the credit secured by any such Lien shall have been obtained not later than 18 months after the later of (a) the completion of the acquisition, construction, development or improvement of such Property or (b) the placing in operation of such Property;
(iv)    Liens in favor of the Company or any of its Subsidiaries;
(v)    Liens existing on the date of the initial Issue Date of the Securities of such Series (other than any additional Securities of such Series);
(vi)    Liens created to secure the Securities of such Series;
(vii)    Liens incurred in connection with pollution control, industrial revenue or similar financings;
(viii)    Liens on Property in favor of the United States of America or any state thereof, or in favor of any other country, or any department, agency, instrumentality or political subdivision thereof (including, without limitation, security interests to secure Indebtedness of the pollution control or industrial revenue type) in order to permit the Company or any of its Subsidiaries to perform a contract or to secure Indebtedness incurred for the purpose of financing 
20

all or any part of the purchase price for the cost of constructing or improving the Property subject to such security interests or which is required by law or regulation as a condition to the transaction of any business or the exercise of any privilege, franchise or license;
(ix)    any extension, renewal or replacement (or successive extensions, renewals or replacements), as a whole or in part, of any Indebtedness secured by any Lien referred to in clauses (i) through (viii) and (x), inclusive, provided that (1) such extension, renewal or replacement Lien shall be limited to all or a part of the same Property that secured the Lien extended, renewed or replaced (plus improvements on such Property, and plus any Property relating to a specific project, the completion of which is funded pursuant to clause (2)(b) below), and (2) the Indebtedness secured by such Lien at such time is not increased (other than (a) by an amount equal to any related financing costs (including, but not limited to, the accrued interest and premium, if any, on the Indebtedness being refinanced) and (b) where an additional principal amount of Indebtedness is incurred to provide funds for the completion of a specific project or Property that is subject to a Lien securing the Indebtedness being extended, refinanced or renewed, by an amount equal to such additional principal amount); or
(x)    Liens created in substitution of any Liens permitted by clauses (i) through (ix), inclusive, provided that, (1) based on a good faith determination of a Senior Officer of the Company, the Principal Property encumbered by such substitute or replacement Lien is substantially similar in nature to the Principal Property encumbered by the otherwise permitted Lien that is being replaced, and (2) the Indebtedness secured by such Lien at such time is not increased (other than (a) by an amount equal to any related financing costs (including, but not limited to, the accrued interest and premium, if any, on the Indebtedness being refinanced) and (b) where an additional principal amount of Indebtedness is incurred to provide funds for the completion of a specific project or property that is subject to a Lien securing the Indebtedness being extended, refinanced or renewed, by an amount equal to such additional principal amount).
(c)    Notwithstanding the restrictions set forth in Section 4.06(a) and Section 4.06(b), the Company and its Domestic Subsidiaries may incur secured Indebtedness which would otherwise be subject to such restrictions without equally and ratably securing the Securities of any Series, provided that, after giving effect to such secured Indebtedness, the outstanding aggregate principal amount of all such secured Indebtedness (not including Liens permitted under clauses (i) through (x) of Section 4.06(b) with respect to such Series) does not exceed the greater of (i) 15% of Consolidated Total Assets calculated as of the date of the creation or incurrence of the Lien and (ii) 15% of Consolidated Total Assets calculated as of the date of initial Issue Date of the Securities of such Series. The Company or its Domestic Subsidiaries may also, without equally and ratably securing the Securities of any Series, create or incur Liens that renew, substitute or replace (including successive renewals, substitutions or replacements), in whole or in part, any Lien permitted pursuant to the preceding sentence with respect to such Series.
21

ARTICLE 5
SUCCESSOR PERSON
Section 5.01.    When Company May Merge, etc.
(a)    The Company may consolidate with or merge into another Person or sell, convey, transfer, lease or otherwise dispose of all or substantially all of its Property to any other Person, provided that: 
(i)    (A) the Company is the continuing Person, or (B) the successor formed from the consolidation or merger or the Person that received the transfer of or leases the Property (the “Continuing Entity”) is a Person organized and existing under the laws of the United States of America, any State thereof or the District of Columbia and expressly assumes, by an indenture supplemental hereto, all of the Company’s obligations under the Securities and the Indenture;
(ii)    immediately after giving effect to the transaction, no Event of Default shall have occurred and be continuing under this Indenture; and
(iii)    the Company or the Continuing Entity delivers to the Trustee an Officer’s Certificate and an Opinion of Counsel, subject to customary qualifications and exceptions, each stating that the transaction and (if a supplemental indenture is required in connection with such transaction) the supplemental indenture complies with this Section 5.01 and that all conditions precedent in this Indenture relating to the transaction have been satisfied.
(b)    Upon satisfaction of the foregoing conditions, if the Company is not the continuing Person, then the Continuing Entity shall succeed to, and be substituted for, and may exercise every right and power of the Company under the Indenture and the Company will be released from all obligations and covenants under the Indenture and the Securities; provided that, in the case of a lease of all or substantially all of the Company’s Property, the Company will not be released from any of the obligations or covenants under the Indenture and the Securities.
(c)    Notwithstanding anything in this Section 5.01, any sale, conveyance, transfer, lease or other disposition of Property between or among the Company and its Subsidiaries will not be prohibited under the Indenture.
ARTICLE 6
DEFAULTS AND REMEDIES
Section 6.01.    Events of Default.  Each of the following events shall constitute an “Event of Default” with respect to a Series of Securities:
(a)    default in the payment of the principal of or premium, if any, on any Security of such Series when due at its stated maturity date, upon any optional or mandatory redemption or otherwise;
22

(b)    default in the payment of any interest upon any Security of such Series when it becomes due and payable (if the time of payment has not been extended or deferred), and continuance of such default for a period of 30 days;
(c)    default in the performance, or breach, of any covenant of the Company in the Indenture relating to the Securities of such Series (other than a covenant a default in whose performance or whose breach is elsewhere in this Section 6.01 specifically dealt with), and continuance of such default or breach for a period of 90 days after there has been given, by registered or certified mail, or overnight delivery service to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in aggregate principal amount of the outstanding Securities of such Series a written notice specifying such default or breach and stating that such notice is a “Notice of Default” under the Indenture;
(d)    the entry by a court having jurisdiction in the premises of (i) a decree or order for relief in respect of the Company in an involuntary case or proceeding under any applicable Federal or State bankruptcy, insolvency, reorganization or other similar law or (ii) a decree or order adjudging the Company a bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in respect of the Company under any applicable Federal or State law, or appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or of all or substantially all of its Property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree or order for relief or any such other decree or order unstayed and in effect for a period of 90 consecutive days; and
(e)    the commencement by the Company of a voluntary case or proceeding under any applicable Federal or State bankruptcy, insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the consent by it to the entry of a decree or order for relief in respect of the Company in an involuntary case or proceeding under any applicable Federal or State bankruptcy, insolvency, reorganization or other similar law or to the commencement of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under any applicable Federal or State law, or the consent by it to the filing of such petition or to the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or of all or substantially all of its Property, or the making by it of a general assignment for the benefit of creditors, or the admission by it in writing of its inability to pay its debts generally as they become due.
Section 6.02.    Acceleration.  If an Event of Default (other than an Event of Default pursuant to Section 6.01(d) or Section 6.01(e)) occurs and is continuing with respect to a Series of Securities, then the Trustee or the Holders of not less than 25% in aggregate principal amount of the outstanding Securities of such Series may, by a notice in writing to the Company (and to the Trustee if given by Holders), declare the principal amount of all such Securities of such Series, plus accrued and unpaid interest, if any, on such Securities of such Series to be due and payable immediately, and upon any such declaration such principal amount and accrued and unpaid interest shall become 
23

immediately due and payable. However, upon an Event of Default pursuant to Section 6.01(d) or Section 6.01(e), the principal amount of all outstanding Securities of such Series, plus accrued and unpaid interest, if any, on all outstanding Securities of such Series to the acceleration date, shall be due and payable immediately without any declaration or other act on the part of the Trustee or any Holder.
At any time after such a declaration of acceleration with respect to the Securities of a Series has been made but before a judgment or decree for payment of the money due has been obtained by the Trustee, the Holders of a majority in aggregate principal amount of the outstanding Securities of such Series, by written notice to the Trustee, may rescind and annul such declaration and its consequences if all Events of Default, other than the non-payment of the principal and interest, if any, of Securities of such Series which have become due solely as a result of such declaration of acceleration, have been cured or waived as provided in Section 6.04 hereof. No such rescission shall affect any subsequent Default or impair any right consequent thereon.
In case the Trustee shall have proceeded to enforce any right under the Indenture and such proceedings shall have been discontinued or been abandoned because of such rescission or annulment or for any other reason or shall have been determined adversely to the Trustee, then and in every such case the Company and the Trustee shall be restored respectively to their several positions and rights hereunder, and all rights, remedies and powers of the Company and the Trustee shall continue as though no such proceedings had been taken.
Section 6.03.    Other Remedies.  If an Event of Default with respect to a Series occurs and is continuing, the Trustee may pursue any available remedy by proceeding at law or in equity to collect the payment of principal of or interest on such Series or to enforce the performance of any provision in the Securities of such Series or this Indenture applicable to the Series.
The Trustee may maintain a proceeding even if it does not possess any of the Securities or does not produce any of them in the proceeding.  A delay or omission by the Trustee or any Securityholder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default.  No remedy is exclusive of any other remedy.  All available remedies are cumulative.
Section 6.04.    Waiver of Existing Defaults.  Subject to the last sentence of the first paragraph of Section 9.02, the Holders of a majority in aggregate principal amount of the outstanding Securities of a Series affected by a waiver on behalf of all the Holders of such Series by notice to the Trustee have the right to waive an existing Default on such Series and its consequences.  When a Default is waived, it is cured and stops continuing, and any Event of Default arising therefrom shall be deemed to have been cured; but no such waiver shall extend to any subsequent or other Default or impair any right consequent thereon.
24

Section 6.05.    Control by Majority.  The Holders of a majority in principal amount of the outstanding Securities of a Series may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee with respect to such Series.  The Trustee, however, may refuse to follow any direction (a) that conflicts with law or this Indenture, (b) that, subject to Section 7.01, the Trustee determines is unduly prejudicial to the rights of other Securityholders, (c) that would involve the Trustee in personal liability, if there shall be reasonable grounds for believing that adequate indemnity against such liability is not reasonably assured to it, or (d) if the Trustee shall not have been provided with indemnity satisfactory to it.
Section 6.06.    Limitation on Suits.  No Securityholder of any Security of any Series will have any right to institute any proceeding, judicial or otherwise, with respect to the Indenture or for the appointment of a receiver or trustee, or for any remedy under the Indenture unless:
(a)    that Holder has previously given to the Trustee written notice of a continuing Event of Default with respect to such Series of Securities;
(b)    the Holders of at least 25% in aggregate principal amount of the outstanding Securities of such Series have made a written request to the Trustee, and offered indemnity reasonably satisfactory to the Trustee, to institute the proceeding as Trustee; and
(c)    the Trustee has failed to comply with the request for at least 60 days after receipt of the request and the offer of indemnity, and has not received from the Holders of a majority in aggregate principal amount of the outstanding Securities of such Series a direction inconsistent with that request.
A Securityholder may not use this Indenture to prejudice the rights of another Holder of Securities of the same Series or to obtain a preference or priority over another Holder of Securities of the same Series (it being understood that the Trustee does not have an affirmative duty to ascertain whether or not such actions or forbearances by such Holder are unduly prejudicial to another Holder).
Section 6.07.    Rights of Holders to Receive Payment.  Notwithstanding any other provision of this Indenture, the right of any Holder to receive payment of principal of and interest on any Security, on or after the respective due dates expressed in the Security, or to bring suit for the enforcement of any such payment on or after such respective dates, is absolute and unconditional and shall not be impaired or affected without the consent of the Holder.
Section 6.08.    Collection Suit by Trustee.  If an Event of Default in payment of interest or principal specified in Section 6.01(a) or (b) occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company for the whole amount of principal and interest remaining unpaid.
25

Section 6.09.    Trustee May File Proofs of Claim.  The Trustee may file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements, and advances of the Trustee, its agents and counsel) and the Securityholders allowed in any judicial proceedings relative to the Company or its creditors or Property, and unless prohibited by applicable law or regulation, may vote on behalf of the Holders in any election of a custodian, and shall be entitled and empowered to collect and receive any moneys or other Property payable or deliverable on any such claims and to distribute the same and any custodian in any such judicial proceeding is hereby authorized by each Securityholder to make such payments to the Trustee.  Nothing herein shall be deemed to authorize the Trustee to authorize or consent to or vote for or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder or to authorize the Trustee to vote in respect of the claim of any Securityholder except as aforesaid for the election of the custodian.
Section 6.10.    Priorities.  If the Trustee collects any money or Property pursuant to this Article with respect to Securities of any Series, it shall pay out the money in the following order:
First:    to the Trustee (acting in its capacity as such) for all amounts due under Section 7.07;
Second:    to Securityholders of the Series for amounts due and unpaid on the Series for principal and interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Series for principal and interest, respectively; and
Third:    to the Company or as a court of competent jurisdiction shall direct.
The Trustee may fix a record date and payment date for any payment to Securityholders pursuant to this Section 6.10.
Section 6.11.    Undertaking for Costs.  In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in the suit, having the due regard to the merits and good faith of the claims or defenses made by the party litigant.  This Section does not apply to a suit by the Trustee, a suit by a Holder pursuant to Section 6.07 or a suit by Holders of more than 10% in principal amount of the Series.
ARTICLE 7
TRUSTEE
Section 7.01.    Duties of Trustee.
26

(a)    If an Event of Default has occurred and is continuing with respect to Securities of any Series, the Trustee shall, prior to the receipt of direction from the Holders of a majority in principal amount of the Securities of the Series, exercise its rights and powers and use the same degree of care and skill in their exercise as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs.
(b)    Except during the continuance of an Event of Default:
(i)    The Trustee need perform only those duties that are specifically set forth in this Indenture and no others and no implied covenants or obligations shall be read into this Indenture against the Trustee.
(ii)    In the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture.  The Trustee, however, in the case of certificates or opinions specifically required by any provision hereof to be furnished to it, shall examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture but need not confirm or investigate the accuracy of mathematical calculations or other facts or matters stated therein.
(c)    The Trustee may not be relieved from liability for its own grossly negligent action, its grossly negligent failure to act or its own willful misconduct, as determined by a final non-appealable order of a court of competent jurisdiction, except that:
(i)    This paragraph does not limit the effect of paragraph (b) of this Section 7.01.
(ii)    The Trustee shall not be liable for any error of judgment made in good faith by a Trust Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts.
(iii)    The Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05 or any other direction of the Holders permitted hereunder.
(d)    Every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b) and (c) of this Section 7.01.
(e)    The Trustee may refuse to perform any duty or exercise any right or power if the Trustee has reasonable grounds to believe that such performance or exercise (i) would require the Trustee to expend or risk its own funds or otherwise incur any financial liability in the performance, unless it receives indemnity satisfactory to it against any loss, liability or expense, or (ii) is not in accordance with applicable law.
27

(f)    The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree with the Company.  Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law.
Section 7.02.    Rights of Trustee.  Subject to Section 7.01:
(a)    The Trustee may conclusively rely and shall be fully protected in acting or refraining from acting on any document, resolution, certificate, instrument, report, or direction believed by it to be genuine and to have been signed or presented by the proper person.  The Trustee need not investigate any fact or matter stated in the document, resolution, certificate, instrument, report, or direction.
(b)    Before the Trustee acts or refrains from acting at the request of the Company, it may require an Officer’s Certificate or an Opinion of Counsel or both, which shall conform to Sections 11.04 and 11.05 hereof.  The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on the Officer’s Certificate, Opinion of Counsel or any other direction of the Company permitted hereunder.
(c)    The Trustee may act through agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care.
(d)    The Trustee shall not be liable for any action taken, suffered or omitted by it in good faith and believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Indenture.
(e)    The Trustee may consult with counsel of its selection, and the advice of such counsel or any Opinion of Counsel as to matters of law shall be full and complete authorization and protection in respect of any action taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or opinion of such counsel.
(f)    Unless otherwise specifically provided in the Indenture, any demand, request, direction or notice from the Company shall be sufficient if signed by an Officer of the Company.
(g)    For all purposes under this Indenture, the Trustee shall not be deemed to have notice or knowledge of any Event of Default unless written notice of any Event of Default is received by a Trust Officer of the Trustee at its address specified in Section 11.02 hereof and such notice references the Securities generally, the Company and this Indenture.
(h)    The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders pursuant to this Indenture, unless such Trustee receives indemnity satisfactory to the Trustee against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction.
(i)    The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, 
28

request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company, personally or by agent or attorney at the sole cost of the Company and shall incur no liability or additional liability of any kind by reason of such inquiry or investigation.
(j)    In no event shall the Trustee be responsible or liable for special, indirect, punitive, or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action.
(k)    The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder.
(l)    The Trustee may request that the Company deliver a certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture.
(m)    In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, (i) any act or provision of any present or future law or regulation or governmental authority, (ii) any act of God, (iii) natural catastrophes, (iv) war, (v) terrorism, (vi) civil disturbances, (vii) accidents, (viii) labor dispute, (ix) disease, (x) epidemic or pandemic, (xi) quarantine, (xii) national emergency, (xiii) loss or malfunction of utility or computer software or hardware, (xiv) communications system failure, (xv) malware or ransomware or (xvi)  unavailability of the Federal Reserve Bank wire or telex system or other wire or other funds transfer systems, or (xvii) unavailability of any securities clearing system; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.
(n)    The permissive rights of the Trustee enumerated herein shall not be construed as duties.
(o)    The Trustee shall not be required to give any bond or surety in respect of the performance of its powers and duties hereunder.
Section 7.03.    Individual Rights of Trustee.  The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or its affiliates with the same rights it would have if it were not Trustee.  Any Agent may do the same with like rights.  The Trustee, however, must comply with Sections 7.10 and 7.11.
29

Section 7.04.    Trustee’s Disclaimer.  The Trustee makes no representation as to the validity or adequacy of this Indenture, the Securities or of any prospectus used to sell the Securities of any Series; it shall not be accountable for the Company’s use of the proceeds from the Securities; it shall not be accountable for any money paid to the Company, or upon the Company’s direction, if made under and in accordance with any provision of this Indenture; it shall not be responsible for the use or application of any money received by any Paying Agent other than the Trustee; and it shall not be responsible for any statement of the Company in this Indenture or in the Securities other than its certificate of authentication.
Section 7.05.    Notice of Defaults.  If a Default occurs and is continuing hereunder with respect to a Series of Securities and a Trust Officer of the Trustee has received written notice thereof at the corporate trust office of the Trustee and such notice references the Securities of such Series or the Securities generally and the Indenture and states that it is a “Notice of Default,” the Trustee shall give the Holders of Securities of such Series notice of all Defaults known to the Trustee which have occurred with respect to such Securities within 45 days after receipt thereof, unless such Defaults shall have been cured before the giving of such notice; provided, however, that except in the case of a Default in the payment of principal or redemption price of (or premium, if any) or interest on any Securities, the Trustee shall be protected in withholding such notice if and so long as its board of directors, executive committee, or trust committee of directors or trustees and/or Trust Officers of the Trustee in good faith determine that the withholding of such notice is in the interests of the Holders of Securities of such Series.
Section 7.06.    Reports by Trustee to Holders.  Within 60 days after each May 15 beginning with the May 15 following the date of this Base Indenture, the Trustee shall send to each Securityholder a brief report dated as of such May 15 that complies with TIA § 313(a) (but if no event described in TIA §§ 313(a)(1) through (8) has occurred within the twelve months preceding the reporting date no report in relation thereto need be transmitted).  The Trustee also shall comply with TIA § 313(b).
A copy of each report at the time of its sending to Securityholders shall be delivered to the Company and filed by the Trustee with the Commission and each national securities exchange on which the Securities are listed.  The Company agrees to notify the Trustee of each national securities exchange on which the Securities are listed.
Section 7.07.    Compensation and Indemnity.  The Company shall pay to the Trustee from time to time reasonable compensation for its services subject to any written agreement between the Trustee and the Company (which compensation shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust).  The Company shall reimburse the Trustee upon request for all reasonable out-of-pocket expenses incurred by it.  Such expenses shall include the reasonable compensation and expenses of the Trustee’s agents and counsel.  The Company shall indemnify the Trustee, its officers, directors, employees and agents and hold it harmless against any loss, liability, fee, cost, damage or expense incurred or made by or on behalf of it in connection with the administration of this Indenture or the trust hereunder and its duties hereunder including the costs and expenses of defending itself against or investigating 
30

any claim in the premises and the costs and expenses (including reasonable attorneys’ fees and expenses and court costs) incurred in connection with any action, claim or suit brought to enforce the Trustee’s right to indemnification.  The Trustee shall notify the Company promptly of any claim of which it has received written notice and for which it may seek indemnity, but failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder.  The Company need not reimburse any expense or indemnify against any loss, liability, fee, cost or damage incurred by the Trustee through the Trustee’s, or its officers’, directors’ or employees’ gross negligence or willful misconduct as determined by a final non-appealable order of a court of competent jurisdiction.
Unless otherwise provided in any supplemental indenture, Officer’s Certificate or Authorizing Resolution relating to any Series, to ensure the Company’s payment obligations in this Section, the Trustee shall have a lien prior to the Securities of all Series on all money or Property held or collected by the Trustee, except that held in trust to pay principal of or interest on particular Securities.  When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 6.01 or in connection with Article 6 hereof, the expenses (including the reasonable fees and expenses of its counsel) and the compensation for services in connection therewith are to constitute expenses of administration under any Bankruptcy Law.  This Section 7.07 shall survive the discharge of the Indenture or the resignation or removal of the Trustee.
Section 7.08.    Replacement of Trustee.  The Trustee may resign with respect to Securities of any or all Series by so notifying the Company.  The Holders of a majority in principal amount of the outstanding Securities (or of the relevant Series) may remove the Trustee by so notifying the removed Trustee in writing and may appoint a successor trustee with the Company’s consent.  The Trustee for one or more Series of Securities may be removed by the Company, so long as no Event of Default has occurred and is continuing with respect to such Series.  The Trustee may also be removed by the Company for purposes of the Base Indenture.  Such resignation or removal shall not take effect until the appointment by the Securityholders of the relevant Series or the Company as hereinafter provided of a successor trustee and the acceptance of such appointment by such successor trustee.  The Company may remove the Trustee and appoint a successor trustee, and any Securityholder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee, for any or no reason, including if:
(a)    the Trustee fails to comply with Section 7.10 after written request by the Company or any bona fide Securityholder who has been a Securityholder for at least six months;
(b)    the Trustee is adjudged a bankrupt or an insolvent;
(c)    a receiver or other public officer takes charge of the Trustee or its Property; or
(d)    the Trustee becomes incapable of acting.
31

If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a successor trustee with respect to the Securities of the relevant Series.  If a successor trustee does not take office within 30 days after the retiring Trustee resigns or is removed, the retiring Trustee at the expense of the Company, the Company or any Holder may petition any court of competent jurisdiction for the appointment of a successor trustee.
A successor trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company.  Immediately after that, the retiring Trustee shall, upon payment of its charges hereunder, transfer all Property held by it as Trustee to the successor trustee, the resignation or removal of the retiring Trustee shall become effective, and the successor trustee shall have all the rights, powers and duties of the Trustee under this Indenture.  A successor trustee shall send notice of its succession to each Securityholder.
Section 7.09.    Successor Trustee by Merger, etc.  If the Trustee consolidates with, merges with or into or converts into, or transfers all or substantially all of its corporate trust business to, another corporation, the successor corporation without any further act shall be the successor trustee.
Section 7.10.    Eligibility; Disqualification.  This Indenture shall always have a Trustee who satisfies the requirements of TIA § 310(a)(1).  The Trustee shall have a combined capital and surplus of at least $10,000,000 as set forth in its most recent published annual report of condition.  The Trustee shall comply with TIA § 310(b).
Section 7.11.    Preferential Collection of Claims Against Company.  The Trustee shall comply with TIA § 311(a), excluding any creditor relationship listed in TIA § 311(b).  A Trustee who has resigned or been removed shall be subject to TIA § 311(a) to the extent indicated therein.
ARTICLE 8
DISCHARGE OF INDENTURE
Section 8.01.    Defeasance upon Deposit of Moneys or Government Obligations; Satisfaction and Discharge.  
(a)    The Company may, at its option and at any time, elect to have either paragraph (b) or paragraph (c) below be applied to the outstanding Securities of any Series upon compliance with the applicable conditions set forth in paragraph (d) below.
(b)    Upon the Company’s exercise under paragraph (a) above of the option applicable to this paragraph (b) with respect to any Series, the Company shall be deemed to have been released and discharged from its obligations with respect to the outstanding Securities of such Series on the date the applicable conditions set forth below are satisfied (hereinafter, “Legal Defeasance”).  For this purpose, such Legal Defeasance means that the Company shall be deemed to have paid and discharged the entire indebtedness represented by the outstanding Securities of such Series, which shall thereafter be 
32

deemed to be “outstanding” only for the purposes of the Sections and matters under this Indenture referred to in (i) and (ii) below, and the Company shall be deemed to have satisfied all its other obligations under such Securities and this Indenture insofar as such Securities are concerned, except for the following which shall survive until otherwise terminated or discharged hereunder: (i) the rights of Holders of outstanding Securities of such Series to receive solely from the trust fund described in paragraph (d) below and as more fully set forth in such paragraph, payments in respect of the principal of and interest on such Securities when such payments are due, (ii) the Company’s obligations with respect to such Securities under Section 2.06, Section 2.07, Section 2.09 and Section 4.02, (iii) the rights, powers, trusts, duties, immunities and other provisions in respect of the Trustee hereunder and (iv) this Article 8.  The Company may exercise its option under this paragraph (b) with respect to a Series notwithstanding the prior exercise of its option under paragraph (c) below with respect to the Securities of such Series.
(c)    Upon the Company’s exercise under paragraph (a) above of the option applicable to this paragraph (c) with respect to any Series, the Company shall be released and discharged from the obligations with respect to such Series under Section 4.05, Section 4.06 and Section 5.01 and any other covenant contained in or referenced in the Authorizing Resolution, Officer’s Certificate or supplemental indenture relating to such Series (to the extent such release and discharge shall not be prohibited thereby), on and after the date the conditions set forth below are satisfied (hereinafter, “Covenant Defeasance”), and the Securities of such Series shall thereafter be deemed to be not “outstanding” for the purpose of any direction, waiver, consent or declaration or act of Holders (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed “outstanding” for all other purposes hereunder.  For this purpose, such Covenant Defeasance means that, with respect to the outstanding Securities of such Series, the Company may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a Default or an Event of Default under Section 6.01(c) or otherwise, but, except as specified above, the remainder of this Indenture and such Securities shall be unaffected thereby.
(d)    The following shall be the conditions to the application of either paragraph (b) or paragraph (c) above to the outstanding Securities of any Series:
(i)    The Company shall have irrevocably deposited in trust with the Trustee (or another qualifying trustee) money in the currency in which the Securities of such Series are payable or Government Obligations or a combination thereof in such amounts and at such times as are sufficient (in the case of Government Obligations or a combination of money and Government Obligations, in the opinion of a nationally recognized firm of independent public accountants), to pay the principal of and interest on the outstanding Securities of such Series to maturity or redemption; provided, however, that the Trustee (or other qualifying trustee) shall have received an irrevocable written order from the Company instructing the Trustee (or other qualifying trustee) to apply such 
33

money or the proceeds of such Government Obligations to said payments with respect to the Securities of such Series to maturity or redemption;
(ii)    No Default or Event of Default (other than a Default or Event of Default resulting from non-compliance with any covenant from which the Company is released upon effectiveness of such Legal Defeasance or Covenant Defeasance pursuant to paragraph (b) or (c) hereof, as applicable) shall have occurred and be continuing on the date of such deposit or result therefrom;
(iii)    Such deposit will not result in a breach or violation of, or constitute a default under, any other material instrument or agreement to which the Company is a party or by which it or any of its Property is bound;
(iv)    (A) In the event the Company elects paragraph (b) hereof, the Company shall deliver to the Trustee an Opinion of Counsel in the United States stating that (1) the Company has received from, or there has been published by, the Internal Revenue Service a ruling or (2) since the Issue Date pertaining to such Series, there has been a change in the applicable federal income tax law, in either case stating that, and based thereon such Opinion of Counsel shall state that, or (B) in the event the Company elects paragraph (c) hereof, the Company shall deliver to the Trustee an Opinion of Counsel in the United States stating that, in the case of clauses (A) and (B), and subject to customary assumptions and exclusions, Holders of the Securities of such Series will not recognize income, gain or loss for federal income tax purposes as a result of such deposit and the defeasance contemplated hereby and will be subject to federal income tax in the same amounts and in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred;
(v)    The Company shall have delivered to the Trustee an Officer’s Certificate, stating that the deposit made under clause (i) was not made by the Company with the intent of preferring the Holders of the Securities of such Series over any other creditors of the Company or with the intent of defeating, hindering, delaying or defrauding any other creditors of the Company or others; and
(vi)    The Company has delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that all conditions precedent specified herein relating to the defeasance contemplated by this Section 8.01 have been complied with.
In the event all or any portion of the Securities of a Series are to be redeemed through such irrevocable trust, the Company must make arrangements satisfactory to the Trustee, at the time of such deposit, for the giving of the notice of such redemption or redemptions by the Trustee in the name and at the expense of the Company.
(e)    The Indenture will be discharged and will cease to be of further effect as to all outstanding Securities of any Series (except as to any surviving rights of conversion or transfer or exchange of Securities of such Series expressly provided for herein or in the 
34

form of Security for such Series), and the Trustee, at the expense of the Company, shall execute instruments reasonably requested by the Company acknowledging such satisfaction and discharge of the Indenture with respect to such Series, when:
(i)    All Securities of such Series theretofore authenticated and delivered (other than Securities that have been destroyed, lost or stolen and which have been replaced or paid as provided in Section 2.07 and Securities for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company or discharged from such trust) have been delivered to the Trustee for cancellation in accordance with the Indenture, or, if not delivered to the Trustee, such Securities of such Series (A) have become due and payable, (B) will become due and payable at maturity within one year or (C) are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company, and in the case of clauses (i)(A), (B) and (C) above, the Company has irrevocably deposited or caused to be deposited with the Trustee (or another qualifying trustee) as trust funds in trust solely for that purpose an amount of money in the currency in which the Securities of such Series are payable or Government Obligations or a combination thereof sufficient (in the case of Government Obligations or a combination of money and Government Obligations, in the opinion of a nationally recognized firm of independent public accountants) to pay and discharge the entire indebtedness on the Securities of such Series not theretofore delivered to the Trustee for cancellation, for principal of and interest on the Securities of such Series, on the date of such deposit or to the maturity or redemption date, as the case may be; provided that if on the date of the deposit, the interest payable to, but excluding, or any premium payable on, the stated maturity or redemption date cannot be calculated, the amount deposited shall be sufficient to the extent that an amount is deposited with the Trustee equal to the interest payable to, but excluding, or the premium payable on, the stated maturity or the redemption date calculated as of the date of the deposit, with any deficit on the stated maturity or redemption date, as applicable (any such amount, the “Applicable Deficit”), only required to be deposited with the Trustee on or prior to the stated maturity or redemption date, as applicable; provided, further, any Applicable Deficit shall be set forth in an Officer’s Certificate delivered to the Trustee simultaneously with the deposit of the Applicable Deficit that confirms that the Applicable Deficit shall be applied to the interest or other amounts payable at the stated maturity or on the redemption date, as applicable;
(ii)    The Company has paid or caused to be paid all other sums payable under the Indenture by the Company;
(iii)    The Company has delivered irrevocable instructions to the Trustee (or such other qualifying trustee), to apply the deposited money toward the payment of the Securities of such Series at maturity or redemption, as the case may be; and
35

(iv)    The Company has delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, stating that all conditions precedent specified in this Section 8.01(e) relating to the satisfaction and discharge of this Indenture have been complied with.
Section 8.02.    Survival of the Company’s Obligations.  Notwithstanding the satisfaction and discharge of this Indenture with respect to any Series under Section 8.01(e), the obligations of the Company to the Trustee under Section 7.07, and, if money shall have been deposited with the Trustee pursuant to Section 8.01(e)(i), the obligations of the Trustee under Section 8.03 and Section 8.04 shall survive.
Section 8.03.    Application of Trust Money.  The Trustee shall hold in trust money or Government Obligations deposited with it pursuant to Section 8.01.  It shall apply the deposited money and the money from Government Obligations in accordance with this Indenture to the payment of principal of and interest on the Securities of the defeased or discharged Series.
Section 8.04.    Repayment to the Company.  The Trustee and the Paying Agent shall promptly pay to the Company upon request any excess money or securities held by them at any time.  The Trustee and the Paying Agent shall pay to the Company any money held by them for the payment of principal or interest that remains unclaimed for two years, provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Company cause to be published once in a newspaper of general circulation in the City of New York or send to each such Holder notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such publication or sending, any unclaimed balance of such money then remaining will be repaid to the Company.  After payment to the Company, Securityholders entitled to the money must look solely to the Company for payment unless applicable abandoned property law designates another Person and all liability of the Trustee or such Paying Agent with respect to such money shall cease.
Section 8.05.    Reinstatement.  If the Trustee is unable to apply any money or Government Obligations in accordance with Section 8.01 (b) or (c) by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s obligations under this Indenture and the Securities relating to the Series shall be revived and reinstated as though no deposit had occurred pursuant to Section 8.01 (b) or (c), as applicable until such time as the Trustee is permitted to apply all such money or Government Obligations in accordance with Section 8.01 (b) or (c), as applicable; provided, however, that (a) if the Company has made any payment of interest on or principal of any Securities of the Series because of the reinstatement of its obligations hereunder, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money or Government Obligations held by the Trustee and (b) unless otherwise required by any legal proceeding or any order or judgment of any court or governmental authority, the Trustee shall return all such money or Government Obligations to the Company promptly after receiving a written request 
36

therefor at any time, if such reinstatement of the Company’s obligations has occurred and continues to be in effect.
ARTICLE 9
AMENDMENTS, SUPPLEMENTS AND WAIVERS
Section 9.01.    Without Consent of Holders.  The Company and the Trustee may amend or supplement this Indenture or the Securities of a Series without notice to or consent of any Securityholder of such Series:
(a)    to cure any ambiguity or to correct or supplement any provision of the Indenture which may be defective or inconsistent with any other provision in the Indenture or the Securities of any Series;
(b)    to comply with Article 5 (or any other provisions of the Indenture regarding the consolidation or merger of the Company or the sale, conveyance, transfer, lease or other disposition of all or substantially all of its Property);
(c)    to create a Series and establish its terms;
(d)    to provide for uncertificated Securities in addition to or in place of Definitive Securities;
(e)    to add a guarantor or obligor in respect of any Series;
(f)    to secure any Series;
(g)    to add to the covenants of the Company for the benefit of the Holders of all or any Series or to surrender any right or power conferred upon the Company by the Indenture;
(h)    to add any additional Events of Default for the benefit of Holders of all or any Series;
(i)    to comply with requirements of the Commission in order to effect or maintain the qualification of this Indenture under the TIA;
(j)    to evidence and provide for the acceptance of the appointment of a successor Trustee with respect to the Securities of one or more Series and to add to or change any of the provisions of the Indenture or any supplemental indenture as shall be necessary to provide for or facilitate the administration of the trusts under such Indenture or supplemental indenture by more than one Trustee pursuant to the requirements set forth in the Indenture;
(k)    to make any change that does not adversely affect the rights of any Securityholder in any material respect; or
37

(l)    to conform the provisions of the Indenture to the final offering document in respect of any Series.
After an amendment under this Section 9.01 becomes effective, the Company shall send notice of such amendment to the Securityholders (with a copy to the Trustee).
Section 9.02.    With Consent of Holders.  The Company and the Trustee may amend or supplement this Indenture or the Securities of a Series without notice to any Securityholder of such Series but with the written consent of the Holders of at least a majority in principal amount of the outstanding Securities of each Series affected by the amendment or supplement (voting as one class) (including consents obtained in connection with a purchase of, or tender offer or exchange offer for, Securities of such Series).  The Holders of a majority in principal amount of the outstanding Securities of each Series affected by a waiver (voting as one class) may waive any existing Default under, or compliance with, any provision of the Securities of each such Series or of this Indenture relating to each such Series without notice to any Securityholder (including any waiver granted in connection with a purchase of, or tender offer or exchange offer for, Securities of such Series).  Without the consent of each Holder of a Security affected thereby, however, an amendment, supplement or waiver, including a waiver pursuant to Section 6.04, may not:
(a)    change the stated maturity of the principal of, or any installment of principal of or interest thereon, or reduce the principal amount thereof or the rate of interest thereon or any premium payable upon the redemption thereof, or change any place of payment where, or the coin or currency in which, such Security or any premium or interest thereon is payable, or impair the right to institute suit for the enforcement of any such payment on or after the stated maturity thereof (or, in the case of redemption, on or after the redemption date);
(b)    make any change to Section 6.04, except to increase the percentage in principal amount of Securities of any Series the consent of whose Holders is required for any waiver or to provide that certain other provisions of the Indenture cannot be modified or waived without the consent of the Holder of each outstanding Security affected thereby;
(c)    waive a continuing Default or Event of Default in the payment of the principal of or interest on any Security or a continuing Default or Event of Default in respect of a covenant or a provision of the Indenture that cannot be modified or amended without the consent of all Holders of the applicable Securities; or
(d)    reduce the percentage in principal amount of Securities of any Series the consent of whose Holders is required for any amendment, supplement or waiver.
Any amendment, supplement or waiver which changes or eliminates any covenant or other provision of the Indenture which shall have been included expressly and solely for the benefit of one or more particular Series of Securities, or which modifies the rights 
38

of the Holders of such Series with respect to such covenant or other provision, shall be deemed not to affect the rights of the Holders of any other Series.
It shall not be necessary for the consent of the Holders under this Section to approve the particular form of any proposed supplement, but it shall be sufficient if such consent approves the substance thereof.
Section 9.03.    Compliance with Trust Indenture Act.  From the date on which this Indenture is qualified under the TIA, every amendment to or supplement of this Indenture or any Securities shall comply with the TIA as then in effect.
Section 9.04.    Revocation and Effect of Consents.  A consent to an amendment, supplement or waiver by a Holder shall bind the Holder and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder’s Security, even if notation of the consent is not made on any Security.  Unless otherwise provided in the consent or the consent solicitation statement or other document describing the terms of the consent, any Holder or subsequent Holder may revoke the consent as to its Security or portion of a Security.  Any revocation of a consent by the Holder of a Security or any such subsequent Holder shall be effective only if the Trustee receives the notice of revocation before the date on which the Trustee receives an Officer’s Certificate from the Company certifying that the requisite number of consents have been received.
The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Holders of Securities of any Series entitled to consent to any amendment, supplement or waiver.  If a record date is fixed, and if Holders otherwise have a right to revoke their consent under the consent or the consent solicitation statement or other document describing the terms of the consent, then notwithstanding the second to last sentence of the immediately preceding paragraph, those Persons who were Holders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to revoke any consent previously given, whether or not such Persons continue to be Holders after such record date.
An amendment, supplement or waiver with respect to a Series becomes effective upon the (i) receipt by the Company or the Trustee of the requisite consents, (ii) satisfaction of any conditions to effectiveness as set forth in the Indenture or any indenture supplemental hereto containing such amendment, supplement or waiver and (iii) execution of such amendment, supplement or waiver (or the related supplemental indenture) by the Company and the Trustee.  After an amendment, supplement or waiver with respect to a Series becomes effective, it shall bind every Holder of such Series, unless it makes a change described in any of clauses (a) through (d) of Section 9.02, in which case, the amendment, supplement or waiver shall bind a Holder of a Security who is affected thereby only if it has consented to such amendment, supplement or waiver and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder’s Security.
Section 9.05.    Notation on or Exchange of Securities.  If an amendment, supplement or waiver changes the terms of a Security, the Company may require the 
39

Holder of the Security to deliver it to the Trustee, at which time the Trustee shall place an appropriate notation on the Security about the changed terms and return it to the Holder.  Alternatively, if the Company or the Trustee so determines, the Company in exchange for the Security shall issue and the Trustee shall authenticate a new Security that reflects the changed terms.
Section 9.06.    Trustee to Sign Amendments, etc.  Subject to Section 7.02(b), the Trustee shall sign any amendment, supplement or waiver authorized pursuant to this Article if the amendment, supplement or waiver does not adversely affect the rights, duties, liabilities or immunities of the Trustee.  If it does, the Trustee may, but need not, sign such amendment, supplement or waiver.  In signing or refusing to sign such amendment or supplement or waiver, the Trustee shall be provided with and shall be fully protected in relying upon, an Officer’s Certificate and an Opinion of Counsel as conclusive evidence that such amendment, supplement or waiver is authorized or permitted by this Indenture (it being understood that in no event shall the Company be required to deliver an Opinion of Counsel in connection with the execution of the First Supplemental Indenture hereto, dated as of the date hereof).
ARTICLE 10
SECURITIES IN FOREIGN CURRENCIES
Section 10.01.    Applicability of Article.  Whenever this Indenture provides for (a) any action by, or the determination of any of the rights of, Holders of Securities of any Series in which not all of such Securities are denominated in the same currency, or (b) any distribution to Holders of Securities, in the absence of any provision to the contrary pursuant to this Indenture or the Securities of any particular Series, any amount in respect of any Security denominated in a Foreign Currency shall be treated for any such action or distribution as that amount of Dollars that could be obtained for such amount on such reasonable basis of exchange and as of the record date with respect to Securities of such Series (if any) for such action, determination of rights or distribution (or, if there shall be no applicable record date, such other date reasonably proximate to the date of such action, determination of rights or distribution) as the Company may specify in a written notice to the Trustee or, in the absence of such written notice, as the paying agent or agency or organization, if any, responsible for overseeing such composite currency may determine.  The Trustee shall have no duty to calculate or verify the calculations made pursuant to this Section 10.01.
ARTICLE 11
MISCELLANEOUS
Section 11.01.    Trust Indenture Act Controls.  If any provision of this Indenture limits, qualifies or conflicts with another provision which is required to be included in this Indenture by the TIA, the required provision shall control.
Section 11.02.    Notices.  Any order, consent, notice or communication shall be sufficiently given if in writing and delivered in person or mailed by first-class mail, postage prepaid, or delivered by commercial courier service, addressed as follows:
40

(a)    if to the Company:
GXO Logistics, Inc.
Two American Lane
Greenwich, CT 06831
Attention: Baris Oran
(b)    if to the Trustee:
Wells Fargo Bank, National Association
CTSO Mail Operations, MAC: N9300-070
600 South 4th Street, 7th Floor
Minneapolis, MN 55415
Attention: Theresa M. Jacobson
Email: theresa.m.jacobson@wellsfargo.com
Email: lindsey.widdis@wellsfargo.com
Email: melissa.hancock2@wellsfargo.com
The Company or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications.
Any notice or communication sent to a Securityholder shall be sent electronically or mailed to him by first-class mail, postage prepaid, or delivered by commercial courier service, at his address as it appears on the registration books of the Registrar, or, in the case of Global Securities sent electronically in accordance with the procedures of the Depositary, and shall be sufficiently given to him if so sent within the time prescribed.
Failure to send a notice or communication to a Securityholder or any defect in it shall not affect its sufficiency with respect to other Securityholders.  If a notice or communication is sent in the manner provided above, it is duly given, whether or not the addressee receives it except that notice to the Trustee shall only be effective upon receipt thereof by the Trustee.
If the Company sends notice or communications to the Securityholders, it shall send a copy to the Trustee at the same time.
In addition to the foregoing, the Trustee may accept and act upon notice, instructions or directions pursuant to this Indenture sent by unsecured e-mail, facsimile transmission or other similar unsecured electronic methods.  If the party elects to give the Trustee e-mail or facsimile instructions (or instructions by a similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee’s understanding of such instructions shall be deemed controlling.  The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from the Trustee’s reliance upon and compliance with such instructions notwithstanding such instructions conflict or are inconsistent with a subsequent written instruction.  The party providing electronic instructions agrees to assume all risks arising out of the use of such electronic 
41

methods to submit instructions and directions to the Trustee, including without limitation the risk of the Trustee acting on unauthorized instructions, and the risk of interception and misuse by third parties.
Notwithstanding any other provision of this Indenture or any Security, where this Indenture or any Security provides for notice of any event to a Holder of a Global Security (whether by mail or otherwise), such notice shall be sufficiently given if given to the Depositary (or its designee) pursuant to the standing instructions from the Depositary or its designee.
Section 11.03.    Communications by Holders with Other Holders.  Securityholders may communicate pursuant to TIA § 312(b) with other Securityholders with respect to their rights under this Indenture or the Securities.  The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA § 312(c).
Section 11.04.    Certificate and Opinion as to Conditions Precedent.  Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee:
(a)    an Officer’s Certificate (which shall include the statements set forth in Section 11.05) stating that, in the opinion of the signers (who may rely upon an Opinion of Counsel with respect to matters of law), all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and
(b)    an Opinion of Counsel (which shall include the statements set forth in Section 11.05) stating that, in the opinion of such counsel (who may rely upon an Officer’s Certificate or certificates of public officials as to matters of fact), all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with.
Section 11.05.    Statements Required in Certificate or Opinion.  Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture shall include:
(a)    a statement that the person making such certificate or opinion has read such covenant or condition;
(b)    a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based;
(c)    a statement that, in the opinion of such person, such person has made such examination or investigation as is necessary to enable such person to express an informed opinion as to whether or not such covenant or condition has been complied with; and
(d)    a statement as to whether or not, in the opinion of such person, such condition or covenant has been complied with.
42

Section 11.06.    Rules by Trustee and Agents.  The Trustee may make reasonable rules for action by or a meeting of Securityholders.  The Registrar or Paying Agent may make reasonable rules for its functions.
Section 11.07.    Legal Holidays.  A “Legal Holiday” is a day that is not a Business Day.  If any interest or other payment date of a Security falls on a Legal Holiday, the required payment of principal, premium, if any, or interest will be due on the next succeeding Business Day as if made on the date that the payment was due, and no interest will accrue on that payment for the period from and after that interest or other payment date, as the case may be, to the date of that payment on the next succeeding Business Day.  If this Indenture provides for a time period that ends or requires performance of any non-payment obligation by a day that is not a Business Day, then such time period shall instead be deemed to end on, and such obligation shall instead be performed by, the next succeeding Business Day.
Section 11.08.    Governing Law.  This Indenture and the Securities of each Series shall be governed by and construed in accordance with the laws of the State of New York.
Section 11.09.    No Adverse Interpretation of Other Agreements.  This Indenture may not be used to interpret another indenture, loan or debt agreement of the Company or a Subsidiary.  Any such indenture, loan or debt agreement may not be used to interpret this Indenture.
Section 11.10.    No Recourse Against Others.  All liability described in Paragraph 10 of the Securities of any director, officer, employee or stockholder, as such, of the Company, is, to the fullest extent permitted by applicable law, waived and released.
Section 11.11.    Successors and Assigns.  All covenants and agreements of the Company in this Indenture and the Securities shall bind its successors and assigns.  All agreements of the Trustee in this Indenture shall bind its successors and assigns.
Section 11.12.    Duplicate Originals.  The parties may sign any number of copies of this Indenture.  Each signed copy shall be an original, but all of them together represent the same agreement.  Signatures of the parties hereto transmitted by facsimile or other electronic transmission shall be deemed to be their original signatures for all purposes. This Indenture shall be valid, binding, and enforceable against a party (subject to applicable bankruptcy, insolvency, fraudulent transfer, fraudulent conveyance, reorganization, moratorium and other laws now or hereinafter in effect affecting creditors’ rights or remedies generally and to general principles of equity (including standards of materiality, good faith, fair dealing and reasonableness), whether considered in a proceeding at law or at equity) only when executed and delivered by an authorized individual on behalf of the party by means of (i) any electronic signature permitted by the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, and/or any other relevant electronic signatures law, including relevant provisions of the NYUCC (collectively, “Signature Law”); (ii) an original manual signature; or (iii) a faxed, scanned, or photocopied manual signature.  
43

Each electronic signature or faxed, scanned, or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature.  Each party hereto shall be entitled to conclusively rely upon, and shall have no liability with respect to, any faxed, scanned, or photocopied manual signature, or other electronic signature, of any party and shall have no duty to investigate, confirm or otherwise verify the validity or authenticity thereof.  For avoidance of doubt, original manual signatures shall be used for execution or indorsement of writings when required under the NYUCC or other Signature Law due to the character or intended character of the writings.
Section 11.13.    Severability.  In case any one or more of the provisions contained in this Indenture or in the Securities of a Series shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities.
Section 11.14.    PATRIOT ACT.  The Company acknowledges that in accordance with Section 326 of the U.S.A. Patriot Act, the Trustee, like all financial institutions, and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee.  The Company agrees that it will provide the Trustee with such information as it may reasonably request as required in order for the Trustee to satisfy the requirements of the U.S.A. Patriot Act.
Section 11.15.    Waiver of Jury Trial.  EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE SECURITIES OR THE TRANSACTION CONTEMPLATED HEREBY.
Section 11.16.    Jurisdiction.  The Company and the Trustee, and each Holder of a Security by its acceptance thereof, hereby (i) irrevocably submit to the non-exclusive jurisdiction of any federal or state court sitting in the Borough of Manhattan, the city of New York, over any suit, action or proceeding arising out of or relating to this Indenture and (ii) to the fullest extent permitted by applicable law, irrevocably waive and agree not to assert, by way of motion, as a defense or otherwise, any claim that it is not subject to the jurisdiction of any such court, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.
[Remainder of this page intentionally left blank]
44

IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed, all as of the date first written above.
									
		GXO LOGISTICS, INC.,
as Company

			
			
		By:	/s/ Baris Oran
			Name: Baris Oran
			Title:   Chief Financial Officer

[Signature Page – GXO Logistics Indenture]

									
		WELLS FARGO BANK, NATIONAL ASSOCIATION,
as Trustee

			
			
		By:	/s/ Joel Odenbrett
			Name: Joel Odenbrett
			Title:   AVP

[Signature Page – GXO Logistics Indenture]

EXHIBIT A
						
	No.: _______	CUSIP/ISIN No.: _______

[Title of Security]
GXO Logistics, Inc.
a Delaware corporation
promises to pay to _______________________ or registered assigns the principal sum of _______________________ [Dollars]* on _______________________.
Interest Payment Dates:_______________________ and __________________________ Record Dates: _______________________ and _______________________
*Or other currency.  Insert corresponding provisions on reverse side of Security in respect of foreign currency denomination or interest payment requirement.
A-1

IN WITNESS WHEREOF, the parties have caused this instrument to be duly executed.
									
		GXO LOGISTICS, INC.
			
			
		By:	
			Name:
			Title:
	Dated:		

A-2

									
	TRUSTEE’S CERTIFICATE OF AUTHENTICATION
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
as Trustee, certifies that this is one of the Securities
referred to in the within mentioned Indenture.

			
			
		
	By:		
		Authorized Signatory	
			
	Dated: 	

A-3

GXO Logistics, Inc.
[Title of Security]
GXO Logistics, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), issued this Security under the Indenture dated as of July 2, 2021 (as amended, modified or supplemented from time to time in accordance therewith, the “Base Indenture”), as supplemented by the Supplemental Indenture dated as of _________________, (the “Supplemental Indenture” and together with the Base Indenture, the “Indenture”), by and among the Company and Wells Fargo Bank, National Association, as trustee (in such capacity, the “Trustee”), to which reference is hereby made for a statement of the respective rights, obligations, duties and immunities thereunder of the Company, the Trustee and the Holders and of the terms upon which this Security is authorized and delivered.  All terms used in this Security that are defined in the Indenture shall have the meanings assigned to them therein.  If any terms of this Security conflicts with the terms of the Indenture, the terms of the Indenture shall govern and control.
1.    Interest.  The Company promises to pay interest on the principal amount of this Security at the rate of [ ] per year.  The Company will pay interest semi-annually in arrears on _________________ and _________________ of each year, beginning on _________________, _______, until the principal is paid or made available for payment.  Interest on the Securities will accrue from the most recent date to which interest has been paid or duly provided for or, if no interest has been paid, from _________________, _______, provided that, if there is no existing Default in the payment of interest, and if this Security is authenticated between a record date referred to on the face hereof and the next succeeding interest payment date, interest shall accrue from such interest payment date.  Interest will be computed on the basis of a 360-day year comprised of twelve 30-day months, at the office or agency of the Company maintained for that purpose in accordance with the Indenture.
2.    Method of Payment.  The Company will pay interest on this Security (except defaulted interest, if any, which will be paid on a special payment date to Holders of record on such special record date as may be fixed by the Company) to the persons in whose name this Security is registered at the close of business on the _________________ or _________________ immediately preceding the interest payment date.  The Company will pay principal and interest in money of [Insert applicable country or currency] that at the time of payment is legal tender for payment of public and private debts.
3.    Paying Agent and Registrar.  Initially, the Trustee will act as Paying Agent and Registrar.  The Company may change or appoint any Paying Agent, Registrar or co-Registrar in accordance with the Indenture.  The Company or any of its Subsidiaries or any of their Affiliates may act as Paying Agent, Registrar or co-Registrar.
A-4

4.    Optional Redemption.  [Insert provisions relating to redemption at the option of the Company, if any] [Insert provisions relating to redemption at option of Holders, if any]
5.    Mandatory Redemption.  [Insert provisions relating to mandatory redemption, if any]
6.    Persons Deemed Owners.  The registered Holder of this Security shall be treated as the owner of it for all purposes.
7.    Unclaimed Money.  All amounts of principal of and premium, if any, and interest on this Security paid by the Company to the Trustee or Paying Agent that remain unclaimed for two years will be repaid to the Company, and the Holder of this Security will thereafter look solely to the Company for payment unless applicable abandoned property law designates another Person.
8.    Amendment, Supplement, Waiver.  The Indenture or this Security may be amended or supplemented in accordance with the terms of the Indenture.
9.    Successor Person.  When a successor Person assumes all the obligations of its predecessor under the Securities and the Indenture, the predecessor Person will be released from those obligations, in accordance with and except as set forth in the Indenture.
10.    No Recourse Against Others.  A director, officer, employee or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect of or by reason of, such obligations or their creation.  Each Holder by accepting a Security waives and releases all such liability.  The waiver and release are part of the consideration for the issue of the Securities.  
11.    Discharge of Indenture.  The Indenture contains certain provisions pertaining to defeasance and discharge, which provisions shall for all purposes have the same effect as if set forth herein.
12.    Authentication.  This Security shall not be valid until an authorized signatory of the Trustee manually signs the certificate of authentication on the other side of this Security.
13.    Abbreviations.  Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= custodian), and U/G/M/A (= Uniform Gift to Minors Act).
14.    GOVERNING LAW.  This Security shall be governed by and construed in accordance with the laws of the State of New York.
A-5

15.    CUSIP and ISIN Numbers.  Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP and ISIN numbers to be printed on the Securities and has directed the Trustee to use CUSIP and ISIN numbers in notices of repurchase as a convenience to Holders.  No representation is made as to the accuracy of such numbers either as printed on the Securities or as contained in any notice of repurchase and reliance may be placed only on the other identification numbers placed thereon.
16.    Copies.  The Company will furnish to any Holder upon written request and without charge a copy of the Indenture and the applicable Authorizing Resolution or supplemental indenture.  Requests may be made to: GXO Logistics, Inc., Two American Lane, Greenwich, CT 06831, Attention: Baris Oran.
A-6

ASSIGNMENT FORM
To assign this Security, fill in the form below:
I or we assign and transfer this Security to _________________________________ (insert assignee’s social security or tax ID number)
									
			
			
			
			
		(Print or type assignee’s name, address, and zip code)	

and irrevocably appoint ______________________________________________________ agent to transfer this Security on the books of the Company.  The agent may substitute another to act for him.
												
				
				
			
	Date:			
				Your signature
				(Sign exactly as your name appears on the other side of this Security)

						
	Signature Guarantee:	
		
		
		

A-7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]